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1. INTRODUCTION 
Each analytical method provides a sensitive and selective analysis for analytes 
with specific properties. If these properties are not met, analytical derivatization 
can be used in order to extend the applicability or increase the sensitivity of the 
method. This means that the analyte is turned into its derivative which is 
suitable for analysis or more easily analyzed with the respective method.  
Currently, liquid chromatography atmospheric pressure ionization mass 
spectrometry (LC-API-MS) is often the method of choice for analyzing low 
concentrations in complex matrices due to its high sensitivity and selectivity. 
Derivatization can improve all steps of LC-API-MS analysis, starting from the 
sample preparation, increasing chromatographic retention, enhancing ionization 
efficiency and improving structural elucidation with MS. Until now, LC-API-
MS analysis has exploited mainly derivatization reagents which have been 
developed for ultraviolet (UV) or fluorescence (FL) detection. At the same time, 
derivatization reagents aiming at increased ionization efficiency of the analytes 
have been also developed specifically for API-MS analysis.  
In addition to sensitivity, matrix effect (ME) is an important aspect influencing 
both trueness and precision of LC-API-MS analysis. This makes ME an 
essential parameter of quantitative method validation. Therefore, characterization 
of the derivatization reagents is important for achieving analysis which would 
be less affected by ME. The comparison of derivatization reagents is necessary 
for choosing a suitable derivatization reagent for specific applications. In 
addition, this information would be valuable for designing novel derivatization 
reagents which would provide both sensitive and ME free LC-MS analysis. 
The present work aimed at characterization of amino acid derivatization 
reagents from the ME point of view. Amino acids were chosen for model 
analytes as their analysis with reversed phase (RP) chromatography is generally 
carried out using derivatization. Altogether six derivatization reagents, from 
which two have been synthesized in our work group in University of Tartu, 
were applied to the analysis of seven amino acids in standard solutions and 
matrices. Three approaches were used for evaluating ME: post-column infusion, 
post-derivatization spiking and sample dilution experiments. In addition to the 
derivative’s structure, the influence of instrument setup was evaluated for 
comparing ME in case of ESI and APCI, and with one reagent for ESI positive 
and negative ion modes.  
The characterization of six derivatization reagents on the one system (same 
samples and instrument) provided information, which can be useful for 
choosing a suitable derivatization reagent for future applications and for 
designing new derivatization reagents for LC-MS analysis with high sensitivity 
and accuracy. 
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2. REVIEW OF LITERATURE 
2.1. LC-API-MS analysis 
When searching for higher sensitivity and selectivity, liquid chromatography 
mass spectrometry (LC-MS) has become one of the most widely used analytical 
methods applied to the analysis of low concentrations in a wide variety of 
matrices.[1,2] The sample components are first separated chromatographically 
and then by their mass-to-charge ratio (m/z).[3] The use of LC-MS method has 
become more popular with the use of atmospheric pressure ionization (API) 
sources, which connect these two instruments by generating gas phase ions 
from the LC effluent at atmospheric pressure and introducing them to the 
vacuum region of MS.[4,5] The wide applicability of API comes from its ability 
to ionize a wide variety of compounds and from the softness of the ionization 
technique, which preserves the structural integrity of the analyte and results in 
dominating quasimolecular ion in the mass spectra.[3]  
The most widely used electrospray ionization (ESI) source is suitable for 
moderately non-polar to ionic analytes [6] and allows ionization of thermally 
labile, nonvolatile compounds and multiply charged large molecules (e.g. 
proteins).[7] The ionization takes place in the liquid phase as the effluent flows 
through a metal capillary which has electric potential of several kV relative to 
the MS inlet. Due to the electric field, the effluent forms a Taylor cone at the tip 
of the capillary, resulting in a fine mist of charged droplets. The solvent 
evaporation (aided by the gas flow and heating) causes the droplets to shrink to 
the nanometer range until the surface tension is balanced by the Coulombic 
repulsion forces (the Rayleigh limit).[3] From that point forward, there are three 
main mechanisms describing the formation of gas phase ions in ESI: the ion 
evaporation model (IEM) for low molecular weight analytes [7], the charge 
residue model (CRM) for large globular molecules [8] and the chain ejection 
model (CEM) for disordered macromolecules [9]. 
Another widely used ionization technique is atmospheric pressure chemical 
ionization (APCI).[10] Differently from ESI, the ionization takes place after the 
pneumatic nebulization of the effluent into the gas phase. In APCI, the corona 
needle provides electrical charge for ionization – high voltage applied to the 
needle creates a corona discharge, which produces high energy electrons, which 
are able to ionize carrier gas or solvent molecules.[11] Ionization can occur 
according to at least two mechanisms: (1) the charge exchange and (2) the proton 
transfer or hydrogen atom abstraction, resulting in both molecular ions M·+ and 
quasimolecular ions [M+H]+.[12] The higher the corona needle voltage, the 
higher is the ion current.[13]  
Depending on the ionization mode either positively or negatively charged 
ions can be generated with ESI and APCI. In practice, due to different ionization 
mechanism and depending on the application (analyte) either ESI [14,15] or 
APCI [16] or both could allow the most sensitive analysis. 
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2.2. Ionization efficiency 
The sensitivity of the analysis depends on the ionization efficiency (IE) of the 
analyte. IE describes the efficiency of generating gas-phase ions from molecules 
or ions in the solution.[17] IE depends on the analyte and analysis conditions 
(e.g. ion source and mode, solvent) and it can vary to a great extent.  
The two main requirement for high IE in ESI are chargeability and presence 
of non-polar moiety in the molecule structure. Firstly, the ionization in ESI can 
occur via protonation and deprotonation or adduct formation (e.g. NH4+, Na+, 
K+, Cl–) depending on the ionization mode. Therefore, the analyte has to be 
ionic or readily ionizable in the solution or be able to form adducts in the gas 
phase.[18–21] Secondly, as the surface activity of the compound determines its 
ability to move to the surface of the charged droplet and enter the gas phase 
more efficiently, a non-polar region in analyte’s structure is beneficial in both 
positive and negative ion modes.[22] Moreover, non-polar region increases the 
retention in RP-LC and results in elution at higher organic content in the eluent. 
This reduces effluent’s surface tension and lowers boiling point, which in turn 
increase the IE.[23,24] 
Due to the different ionization mechanism in APCI, low solvation energy is 
important for high IE in both ion modes, while gas phase basicity is important 
for positive and gas phase acidity for negative ion mode.[13] In addition, while 
adduct formation can be abundant in case of positive ion mode ESI, adducts are 
usually not observed with APCI.[6,16] For example, it has been hypothesized 
that the sodium ion is not easily volatilized and therefore adducts don’t form in 
the gas phase or the weak interaction of sodium adduct (Na-adduct) is broken in 
high temperature APCI source.[6]  
In order to better understand the ionization processes and predict the IE of 
specific compounds, logIE is used for quantifying IE and experimental logIE 
scales have been previously compiled for ESI [17,25–27] and APCI [28]. The 
most important parameters affecting the logIE through protonation in ESI are 
the basicity of the analyte in solution (pKa of the conjugated acid or pKb) [25] 
and molecular volume [26]. This means that compounds with higher basicity 
and more voluminous molecules ionize better in positive ion mode ESI. The 
logIE scale for APCI indicates some similarities between ESI and APCI 
ionization mechanisms and shows that the compounds with high logIE in ESI 
have high logIE in APCI regardless of the volatility or molecular volume. 
Though, compounds ionizing in both sources generally have higher IE in 
ESI.[28] ESI and APCI are complementary as they are suitable for analytes with 
different polarity: ESI is more suitable for ionic or polar analytes (acidic or 
basic properties in solution), while APCI is more suitable for low- to medium-
polarity analytes.[6]  
One of the experimental factors affecting the logIE is the solvent composition. 
In ESI, the conductivity of the effluent is important and both methanol and 
acetonitrile are suitable from this aspect, however, methanol is often preferred 
due to providing better peak shape for basic compounds in LC and higher 
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sensitivity.[29,30] In APCI, as ionization takes place in the gas phase, analytes 
with higher proton affinity than the solvent have higher logIE. Methanol is 
considered more suitable than acetonitrile due to the relatively lower proton 
affinity.[29,31] As evaporated solvent molecules act as reagent gas, higher 
sensitivity is obtained at higher effluent flow rates.[14]  
When sensitive LC-MS analysis of compounds with low logIE is necessary, 
derivatization can be applied.[23] The desired properties of the derivative 
depend on the ionization source and it’s polarity. While hydrophobic moiety of 
the derivative leads to higher logIE in both ESI ion modes, derivatives with 
permanent charge, e.g. tertiary ammonium ion [32,33] or strong basic center 
[Paper I], are preferred for positive ion mode. Meanwhile, chromatographic 
separation of charged compounds could be challenging due to weak retention in 
RP-LC.[34] In the negative ion mode, acidic functional groups enhance 
logIE.[19] For positive ion APCI analysis, derivatization has been used for 
decreasing the polarity of analyte or introducing an atom with high proton 
affinity, e.g. fatty acids are turned into neutral esters which still contain oxygen 
with high proton affinity.[21] Adding functional groups with high electron-
affinity (e.g. nitro, trifluoromethyl) to neutral steroids has resulted in more 
sensitive negative ion APCI-MS analysis.[35] 
In addition to higher logIE, derivatization offers other advantages for MS 
detection. First, MS signal of the derivative with higher molecular weight is 
further from low molecular weight matrix compounds and noise is 
decreased.[21] Secondly, the ability of the analyte to produce intense and 
characteristic product ions during fragmentation in MS/MS is a prerequisite for 
selective and sensitive analysis. Fragmentation of the derivatives can offer 
additional information about the structure of the analyte and aid the identi-
fication of small molecules.[36]  
Derivatization reagents applied to the amino acid LC-API-MS analysis are 
further discussed in section 2.5. 
 
 
 2.3. Matrix effect 
Signal in LC-MS can be seriously affected by the sample matrix, i.e. the 
components of sample other than the analyte. In general, any influence of 
matrix components on the analytical result caused by the matrix components is 
called matrix effect (ME).[37] In the context of LC-API-MS analysis, ME is the 
change in analyte’s IE caused by the co-eluting sample components.[38] Two 
types of ME can affect the analysis, first, the difference of analyte signal in pure 
solution versus spiked matrix extract (absolute ME), and second, the change of 
signal in different sample lots (relative ME).[39] The interference from the 
sample matrix can influence the quantitative analysis (i.e. precision, trueness, 
limit of detection (LoD) and limit of quantitation (LoQ)), hence, the importance 
of evaluating ME during method development and validation has been 
addressed.[38,40] 
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Investigation of ME began with the study by Tang and Kebarle showing that 
the presence of other electrolytes can reduce sensitivity of the analysis.[41] Since 
then, several models have been suggested for describing this phenomenon. For 
example, analyte’s signal could be altered due to competition for the limited amount 
of excess charge on the surface of ESI droplet or the change in the effluent’s 
viscosity so that the analyte’s ionization is hindered. In addition, unknown 
adducts can form so that the MS would not recognize the ion as the analyte or 
non-volatile compounds can prevent the analyte from leaving the droplet.[42]  
As ME depends on the analyte and matrix or both, the ME should be 
determined for each case. Additionally, ME depends on the ion source, its design 
and polarity.[43,44] King et al. compared the differences of ME in case of ESI 
and APCI. It was concluded that while both solvent and gas phase processes can 
be the cause of ME, the former is dominant in causing ME.[45] Therefore, ESI 
is more susceptible to ME in some cases, e.g. estradiol in human serum and 
tissue [46], for patulin in apple [47], various drug candidates in bioanalysis [48]. 
Moreover, negative ion mode has been shown to be less affected by ME 
compared to positive ion mode.[49] ME can also affect analysis when deri-
vatization is applied [50] and even novel derivatives designed specifically 
aiming at signal enhancement for LC-MS analysis suffer from ME.[51] As ME 
affects quantitative analysis, suitable methods for evaluating its scope, 
eliminating it or taking it into account are needed. 
 
 
2.3.1. Evaluation of ME 
Evaluation of the presence of ME is an important step in LC-MS method 
validation.[40,52] Two of the most often used methods are post-column 
infusion and post-extraction spiking method. Both of these require analyte free 
blank matrix and a standard substance of the analyte. 
The post-column infusion experiment provides qualitative information about 
ME. In order to estimate the influence of sample matrix on the signal of the 
analyte, the effluent of the chromatographic analysis of the blank sample is 
mixed (using a T-piece) with the continuous flow of the analyte solution before 
the ion source. The signal of the analyte is monitored and alterations in the 
signal, other than the influence due to changing eluent composition during 
gradient elution [53], indicate either signal suppression or enhancement caused 
by the components in the sample [54]. 
Quantitative evaluation of ME is sometimes required and this can be done 
with the post-extraction spiking method. ME is evaluated by comparing the 
signals of equal concentration of analyte spiked into blank sample extract (Amatrix) 
and into the solvent (Astandard). The estimate of the ME can be found using Eq. 1, 
where ME values higher than 100% indicate signal enhancement and values 
below 100% indicate signal suppression.[55] 
 
 %ࡹࡱ = ࡭࢓ࢇ࢚࢘࢏࢞࡭࢙࢚ࢇ࢔ࢊࢇ࢘ࢊ ∙ ૚૙૙% Equation 1 
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However, in some cases the requirement to have a blank sample and a 
standard material of the analyte is difficult or even impossible to fulfil. For 
example, analyte free matrix is not available for analysis of endogenous 
substances in biological matrices, where the presence of analytes is an intrinsic 
property of the sample, e.g. amino acids in human plasma.[1] Since ME 
evaluation is also needed in cases when blank samples are not available, 
modifications of the mentioned methods have been used. In case of 
derivatization, there is a possibility to use an underivatized sample as a blank 
sample (does not contain the derivative of the analyte) for post-extraction 
addition and spike it with derivatized analyte standard solution [56,57]. 
However, as the sample is altered during the derivatization, i.e. sample com-
ponents can also be derivatized, their retention time is changed, meaning that 
the components co-eluting with the analyte can also change.  
Moreover, reference materials cannot be obtained for many analytes, e.g. in 
case of derivatization, where reference material could be considered an analyte 
already in derivatized form. Pure standards of derivatives are commercially 
available only for few analytes and derivatization reagents. For certain cases, 
pure derivatives could be either synthesized in-house or purified from the 
derivatization mixture. Uutela et al.[53] used solid-phase extraction (SPE) for 
purifying propyl chloroformate (PrCl) derivatized β-Ala, which was used for 
post-column infusion experiment for evaluating possible ME for other PrCl-
derivatives. Either way it is laborious to obtain pure derivatives and also require 
knowledge and instrumentation often not available for the laboratory. In 
addition, comparison of slopes of standard addition graph and solvent 
calibration graphs have been used for evaluating ME for derivatives of dansyl 
chloride (DNS).[58] 
 
 
2.3.2. Reducing or taking ME into account 
Once the presence and extent of ME has been determined, there are several 
methods proposed for reducing or taking it into account. First of all, in order to 
reduce ME, changes in sample preparation and optimization of instrumental 
parameters could be considered during method development. For example, 
analyte can be extracted from sample using SPE [59], but this can also 
concentrate sample components and does not always eliminate the ME [60]. 
Incorporating derivatization can increase the retention of analytes resulting in 
better separation from matrix components and decreased number of compounds 
co-eluting with the analyte.[30,56,61] Another option is diluting the samples, 
since it has been shown that there is a linear correlation between ME and 
logarithm of sample dilution factor. It was also demonstrated, that 25–40 fold 
dilutions can reduce strong signal suppression and allow acceptable accuracy 
for many analytes.[62] En scores have been previously used for differentiating 
between the analytes affected and not affected by ME. When ME is decreased, 
but not eliminated with dilution, extrapolative dilution approach can be used for 
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taking the ME into account by estimating the analyte concentration at infinite 
dilution, where ME has been eliminated.[63] In addition, selection of suitable 
ion source and ion mode, suitable effluent flow rate (nano-LC or flow splitting 
after LC) can decrease ME.[64,65]  
If the ME is not eliminated, then one of the most effective methods for 
taking the ME into account is matrix matched calibration.[66] This approach 
also needs analyte free matrix and presumes that ME is consistent from sample 
to sample, which does not always hold.[48] If ME is not present or is 
eliminated, solvent based calibration solutions could be used instead of matrix 
matched standards.[67,68] 
Another option for taking ME into account is standard addition method, 
which is resource intensive and there may not be enough sample available.[69] 
Internal standards can also be used and as ME depends on the retention time of 
the analyte, isotopically labelled internal standard (ILIS) are suitable for this 
purpose. This assumes that ILIS is affected by ME to the same extent as the 
analyte and the ratio of the two signals remains constant. Nevertheless, 
differences in ME of the analyte and ILIS can occur.[70,71]  
 
 
2.4. Amino acid analysis 
Amino acids (AAs) can be found in various fields of chemistry. They have an 
important role as the building blocks for proteins and 20 of them are encoded in 
the DNA. In addition, they are the precursors for other vital compounds, e.g. 
hormones, nucleic acids and neurotransmitters.[72] Due to their importance in 
the human physiology, nine of the encoded AAs are considered essential (His, 
Ile, Leu, Lys, Met, Phe, Thr, Trp, Val), as they cannot be synthesized by human 
body and need to be obtained with food.[73] This also means that AA analysis 
is carried out in a wide variety of applications and matrices: pharmaceutical 
industry [74], diagnosis of medical disorders [75], in food and beverages to 
assess AA’s influence on their taste, aroma and color [76] or to determine their 
adulteration [77], geographical or botanical origin [78]. AA content can be used 
to differentiate between varieties of foods such as coffees [79] or teas [80]. In 
addition, depending on the application, analysis at very low concentrations is 
often aimed at, e.g. selenoamino acids in liver cells [81]. 
Most AAs are polar compounds and have poor retention in RP-LC.[82] In 
many cases, derivatization has been used for AA analysis to enhance chromato-
graphic separation and detection.[76] Due to their acidic/basic properties, most 
AAs can be ionized for MS detection in both positive and negative ion modes 
[75,77]. However, effort has to be made in order to analyze free AAs with  
ESI-MS [74,75] and APCI-MS [83]. Moreover, derivatization can improve the 
retention of AAs enabling their chromatographic separation from each other and 
from matrix components and less ME is expected. 
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2.5. AA derivatization for LC-API-MS analysis 
Several aspects need to be kept in mind for successful derivatization. Depending 
on the analyte’s functional group or groups, different reaction types can be used 
for derivatization.[23] Therefore, derivatization reagents should have a reactive 
group corresponding to specific functional group of the analyte and the 
derivatization reaction should be as selective as possible. In addition, fast one-
pot derivatization reaction in mild conditions (e.g. pH, temperature), resulting in 
stable water soluble derivatives is preferred.[51] 
In case of LC-MS, derivatization often aims at enhancing analyte’s logIE. 
Other possible intentions include (1) improving chromatography (selectivity, 
separation and peak shape), (2) facilitating enantiomer separation without chiral 
stationary phase, (3) improving stability or extraction efficiency of analyte, (4) 
removing endogenous interferences (separation from structurally similar 
compounds) and (5) improving structural elucidation.[23] Depending on the 
specific aim of the derivatization, it can be carried out at different steps during 
the analysis and categorized as pre-, on- or post-column derivatization. Since in 
many cases the chromatographic separation is also one of the main aims, pre-
column derivatization is mainly used.[23] This means that derivatization 
focused on API-MS should also meet the criteria set by the previous steps of the 
analysis: sample preparation and chromatographic analysis.[84,85]  
Derivatization reagents for amines and AAs have been discussed in several 
reviews for LC-ESI-MS [23,36,84,86] and LC-APCI-MS analysis [61] and 
some examples are brought in Figure 1. Various derivatization reagents 
originally meant for UV or FL detection have been applied to LC-ESI-MS 
analysis of AAs in positive ion mode. The derivatives of 9-fluorenyl-
methoxycarbonyl chloride, 9-fluorenylmethyl chloroformate (FMOC-Cl) [87], 
5-(dimethyamino)naphthalene-1-sulfonyl chloride (dansyl chloride, DNS) [88] 
and diethyl ethoxymethylenemalonate (DEEMM) [89] have also been analyzed 
in negative ion mode. Although derivatives of FMOC-Cl [90] and DNS [91] 
have been analyzed with LC-APCI-MS, their application for LC-APCI-MS 
analysis of AAs has not been previously published.  
In addition, several novel derivatization reagents aiming at sensitive LC-ESI-
MS analysis have been developed for amines and AAs. For example, p-N,N,N-
trimethylammonioanilyl N´-hydroxysuccinimidyl carbamate iodide (TAHS 
[33], (5-N-Succinimidoxy-5-oxopentyl)triphenylphosphonium bromide (SPTPP) 
[92] and 2,5-dioxopyrrolidin-1-yl N-tri(pyrrolidino)-phosphoranylideneamino 
carbamate (FOSF) [Paper I] provide LoD at subfemtomole to attomole levels. 
The design of the new reagents differs and some of them have been developed 
based on the existing ones. For example, FMOC-Cl, a common blocking group 
in peptide synthesis, has been the starting point for development of several new 
derivatization reagents, e.g. 1,2-benzo-3,4-dihydrocarbazole-9-ethyl chloroformate 
(BCEOC-Cl) [93] and 2-(11H-benzo[a]-carbazol-11-yl) ethyl chloroformate 
(BCEC-Cl) [83] for LC analysis aiming fluorescence detection, but also applied 
for ESI- and APCI-MS analyses, respectively. The development of novel 
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permanently charged TAHS lead to the development of 3-aminopyridyl-N-
hydroxysuccinimidyl carbamate (APDS) without a permanent charge, in order to 
achieve stronger retention in RP-LC.[34] 
Three novel derivatization reagents have been designed in our work group at 
University of Tartu. Firstly, FOSF was developed based on the hydrophilic 
phosphazenes, which have the highest logIEs in ESI IE scale [26] due to a 
practically permanent positive charge (high basicity) and large molecular 
volume. [Paper I] Secondly, two derivatization reagents, dibenzyl ethoxy-
methylenemalonate (DBEMM) and benzyl ethyl ethoxymethylenemalonate 
(EBEMM), were developed based on the structural features of DEEMM, which 
provided LoD values comparable to TAHS. Their design was also based on the 
ESI logIE scale, but differently from FOSF, these structures were designed 
without a permanent charge in order to improve chromatographic separation. 
Moreover, it was important that the structures of DBEMM and EBEMM were 
able to chelate the charge carrier (H+ or Na+) and have a large hydrophobic 
moiety to facilitate ESI ionization.[94] 
Since logIE values of derivatization reagents can help towards the design of 
reagents, logIE values of selected derivatization reagents and respective 
derivatives have been measured. In case of APCI with acetonitrile as eluent, 
logIE values of derivatization reagents decrease in the order of DNS (3.28), 
EBEMM (2.92), DBEMM (2.43) and DEEMM (1.18). In case of ESI with 
acetonitrile, DBEMM (3.56) and EBEMM (3.17) are superior to DEEMM 
(2.04). The DEEMM-derivatives of Phe and Gly have higher logIE (3.79 and 
3.36) compared to respective FMOC-derivatives (3.56 and 3.23) in ESI with 
methanol.[85,94,95] The results demonstrate that derivatization reagents with 
higher logIE can be designed based on the ionization efficiency scales [17,26,28]. 
Five AA derivatization reagents (FOSF, TAHS, DNS, FMOC-Cl and 
DEEMM) have also been compared for LC-MS analysis using standard 
solutions and it was demonstrated that the reagent meant for UV detection 
(DEEMM) can provide LoQ comparable with novel derivatization reagents 
carrying a permanent positive charge (TAHS and FOSF). As a result of absence 
of permanent charge the former also provide better chromatographic separation 
and wider linear ranges.[Paper I]  
However, when choosing the most suitable derivatization reagent, the IE in 
the sense of sensitivity is not the only parameter that needs to be considered. 
For practical applications, especially with complex matrices, the question of ME 
rises. Matrix influence has been evaluated for LC-MS analysis of AAs using 
derivatization, for example, with PrCl [53], DNS [58], 2H,2H,3H,3H-per-
fluoroundecan-1-al [57] and 10-ethyl-acridone-3-sulfonyl chloride (EASC)[56].  
Although ME has been evaluated for specific LC-MS applications, a 
comparison of different derivatization reagents from ME point of view has not 
been conducted on the same instrument and samples. The information about 
ME for analyses using various derivatization reagents would be valuable for 
choosing the best possible reagent during method development depending on 
whether the sensitivity or absence of ME is critical from the analysis point of 
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view. Moreover, this information would support characterizing classical and 
novel derivatization reagents and also provide an input for developing new 
derivatization reagents, which would provide the highest possible ionization 
efficiency at the same time being immune to ME.  
 
 
 
Figure 1. Derivatization reagents applied for LC-MS analysis, which have been 
originally designed for (A) UV or FL and for (B) API-MS detection. The ones used in 
the present work have been marked with asterisk (*).  
Derivatization reagents: 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) 
[96], DNS* [97], FMOC-Cl* [98], DEEMM* [78], TAHS* [33], APDS [34], FOSF* 
[Paper I], DBEMM* [94], EBEMM [94].  
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3. EXPERIMENTAL 
3.1. Chemicals and materials 
Amino acids: The kit of α-amino acids (Sigma), β-Ala (Fluka). Pure derivatives 
of AAs β-Ala- and Gly-FMOC (Fluka), Phe-FMOC (Aldrich), Gly-, Phe- and  
β-Ala-DEEMM (synthesized in-house according to Ref. [99]).  
Derivatization reagents: DEEMM and DNS (Fluka), FMOC-Cl (Aldrich), TAHS 
(synthesized in-house with modifications from Ref. [33]) [Paper III], FOSF 
(synthesized in-house) [Paper III] and DBEMM (synthesized in-house) [94].  
Chemicals for derivatizations: acetic acid (Lach-Ner); acetone (Lach-Ner); 
sodium hydroxide (Chemapol); boric acid, ammonium hydroxide (Reakhim); 
1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) (Fluka). 
Other chemicals: hydrochloric acid (HCl), orthophosphoric acid, sodium 
dihydrogenphosphate (Reakhim), 2-mercaptoethanol (Sigma). 
LC eluents: HPLC grade methanol and acetonitrile (Sigma-Aldrich), formic 
acid and ammonium acetate (Fluka).  
Aqueous solutions were prepared with ultrapure water purified by Millipore 
Milli-Q Advantage A10 (Millipore). 
All reagents were of analytical grade if not otherwise stated. 
Materials: strong cation exchange solid phase extraction (SPE) cartridges 
(Alltech, 500 mg styrenedivinylbenzene polymer), wide-pore paper filter (388 
FILTRAK), syringe filters regenerated cellulose (RC; 0.45 μm, Econofilter, 
Agilent) and cellulose-acetate (GD/X; 0.45 μm, Whatman). 
 
 
3.2. Preparation of standard solutions 
In this work, “pure standard” stands for the derivative of AA, i.e. without any 
excess derivatization reagent, buffer salts or other components used for 
derivatization reaction. In an abbreviation of a specific pure standard amino acid 
is marked first, e.g. Gly-FMOC. “Procedural standard” stands for AA standard 
solution which is derivatized, i.e. contains excess of derivatization reagent, 
reaction by byproducts and buffer components. In an abbreviation of a specific 
procedural standard derivatization reagent is marked first, e.g. DEEMM-Phe. 
Pure derivatives of AAs: 
A calibration graph was constructed using pure standards for evaluating the 
derivatization yield of procedural standards. Stock solutions of each pure 
standard were prepared in methanol at concentration of 50 μg g–1, expressed as 
the concentration of AA (not the derivative). Working solutions (0.5–5 μg g–1) 
were prepared in 0.1 M HCl with 30% methanol. 
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For post-column infusion experiments, stock solutions of each pure standard 
of Gly-, Phe- and β-Ala-FMOC and β-Ala-DEEMM were prepared in acetonitrile 
with 0.1% aqueous formic acid solution (80:20) at two concentration levels: 
40 μg g–1 and 1 mg g–1.  
Procedural standards: 
All procedural standards were prepared by derivatization of AA standard 
solutions. 
Mixture of 7 amino acids: Individual AA stock solutions (4–16 mg g–1) were 
prepared in 0.1 M HCl with 30% methanol. A stock solution of 7 AAs (Arg, 
Asp, Gly, β-Ala, Pro, Trp, Phe) was prepared so that individual AA con-
centration was in the range of 5–12 μg g–1. Working standard solutions with 
appropriate concentrations were prepared prior to derivatization with 0.1 M HCl 
with 30% methanol. 
Mixture of 22 amino acids: Individual AA stock solutions (1.6–6.5 mg g–1) were 
prepared in 0.1 M HCl with 30% methanol. A stock solution of 22 AAs, with 
AA concentrations of 20–28 μg g–1 was prepared. Working standard solutions 
were prepared prior to derivatization by dilution with ultrapure water (Milli-Q) 
in the AA concentration range 8–7000 ng g–1.  
All stock solutions were stored at –20 ºC.  
 
 
3.3. Preparation of samples  
Samples: Green tea was the main sample used for most of the experiments: 
post-column infusion and sample dilution experiments with ESI and APCI (see 
sections 4.2–4.5). Honey samples were involved for sample dilution experi-
ments with ESI (see section 4.3) and, together with 11 herbal extracts, for 
estimating the influence of ionization polarity in case of ESI (see section 4.5). 
Herbs: Green tea (Ahmad Tea, London, Green Tea); herbs purchased from 
local stores: pine growth (Pini gemma), yarrow (Achillea millefolium), heather 
(Calluna vulgaris), linden1 (Tilia cordata), chamomile1 (Chamomilla recutita), 
cowslip (Primula veris)); herbs obtained directly from consumers (self-grown): 
linden2 (Tilia cordata), chamomile2 (Chamomilla recutita), St. John’s wort 
(Hyperici perforatum) and peppermint (Mentha × piperita).  
Honeys: Heather (Calluna Vulgaris) honey from Estonia, honey1 (Fauchon 
Paris: floral honey. Provence), honey2 (Fauchon Paris: Acacia honey. Rhône 
Alpes), honey3 and honey4 were Estonian polyfloral honeys (purchased locally). 
 
Sample preparation methods: 
Preparation of herbal extracts: Sample preparation from Ref. [80] was used for 
all of the herbal extracts (including green tea). 10 mL of Milli-Q was added to 
0.25 g of herb and heated at 80 ºC for 25 min. The mixture was cooled to room 
temperature and filtered through wide pore paper filter. The volume of the 
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extract was taken to 10 mL with Milli-Q water. In addition, as a modification, 
green tea extract with 2-times higher amount of sample (0.5 g) was also 
prepared. 
Solid phase extraction (SPE) procedure: Sample preparation form Ref. [78] 
was carried out for all honeys and one green tea extract. Honey (1 g) or green 
tea extract (1 mL) was diluted with 25 mL of phosphate buffer (0.03 M, pH 
2.12), which was filtered through a wide-pore paper filter. Strong cation 
exchange SPE cartridge was used for extracting AAs from the buffered sample. 
First, the SPE cartridge was conditioned with 10 mL of 0.1 M HCl (4 mL min–1). 
The buffered sample was applied to the cartridge (1.5 mL min–1). AAs were 
eluted from the cartridge with 15 mL ammonium hydroxide (2.5 M, 10% of 
acetonitrile) and the eluate was evaporated to dryness under nitrogen flow. The 
evaporation residue was dissolved in 1 mL (0.25 mL and 0.5 mL for con-
centrated samples) ultrapure water. The extracts were stored at 4 ºC and diluted 
prior to derivatization with Milli-Q water (section 3.5.2). 
 
Derivatization procedures: 
DEEMM: 250 μL of sample was mixed with 375 μL of DEEMM solution (1:50 
in methanol) and 875 μL of borate buffer (0.75 M, pH 9). Derivatized sample 
was kept in the dark at room temperature. The analysis was carried out during 
24–48 h after the derivatization. Derivatized samples were filtered using GD/X 
syringe filter.  
DNS: 100 μL of sample was mixed with 20 μL of NaOH (2 M) and 500 μL of 
DNS solution in acetone (5 mg mL–1 for green tea and 10 mg mL–1 for honey). 
After 45 min in the dark (at 4 ºC) the reaction was ended with 10 μL of con-
centrated ammonium hydroxide. Samples were filtered using RC syringe filter.  
FMOC-Cl: 300 μL of sample was mixed with 300 μL of borate buffer 
(0.75 M, pH 9) and 300 μL of FMOC-Cl solution (1 mg mL–1 in acetonitrile). 
The derivatization reaction was ended after 30 min by adding 300 μL of 
histidine solution (4 mg mL–1). Samples were filtered using RC syringe filter.  
TAHS and FOSF: 10 μL of sample was mixed with 30 μL of borate buffer 
(0.2 M, pH 8.8) and 20 μL of TAHS or FOSF solution in acetonitrile 
(20 mg mL–1). The derivatization reaction was ended after 30 min by adding 
200 μL of acetic acid solution (0.2% in Milli-Q water). Samples were filtered 
using RC syringe filter.  
DBEMM: 50 μL of sample was mixed with 300 μL of DBEMM solution 
(1:150 in isopropanol) and 200 μL of HFIP buffer (0.56 M, pH 9.0). Samples 
can be filtered using either RC or GD/X syringe filters. 
 
 
3.4. LC-API-MS analysis 
Two different instrument setups were used in this work, one with ion trap 
(XCT) mass analyzer and the other with triple quadrupole (QqQ) mass analyzer. 
Following, the operational parameters of these systems are presented. 
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XCT: LC-API-MSn system Agilent Series 1100 LC/MSD Trap XCT was used. 
Detection was carried out using a photodiode array detector (PDA) with 6 mm 
path length flow cell and electrospray (ESI) or atmospheric pressure chemical 
ionization (APCI) interface mass spectrometer (MS). ESI parameters: nebulizer 
gas (nitrogen) pressure 50 psi (345 kPa), drying gas (nitrogen) flow rate 
12 L min–1 and drying gas temperature 350 ºC. Optimized APCI parameters for 
each reagent are presented in Table 1. 
The chromatographic methods, retention times (tR) and the m/z values of the 
7 AA derivatives are in presented Table 2, Table 3 and Table 4, respectively. 
QqQ: LC-ESI-MS/MS system Agilent 1290 UHPLC with Agilent 6495 Triple 
Quad LC/MS with Jet Stream ion source was used. Ion source parameters were 
the following: nebulizer gas (N2) pressure 30 psi (207 kPa), drying gas (N2) 
flow rate 15 L min–1 and temperature 250 ºC, sheath gas (N2) flow rate 
12 L min–1 and temperature 350˚C.  
Analysis of 22 AA derivatives was carried out using analytical column 
Agilent Zorbax RRHD SB-C18 (2.1 × 50 mm, 1.8 μm) with inline filter 0.3 μm 
(Agilent). Eluent components were (A) 0.1% formic acid in water and (B) 
acetonitrile (with 4% Milli-Q water). The following gradient of (B) was used at 
flow rate 0.4 ml min–1: 0–1 min 10%, 1–1.5 min 10–15%, 1.5–4.5 min 15%, 
4.5–6.5 min 15–35%, 6.5–11 min 35%, 11–12 min 35–100%. Injection volume 
was 2 μL. The MS parameters for each analyte are presented in Table 5. 
 
 
Table 1. Optimized values of APCI parameters. Final values different from the default 
values are marked in bold. 
Parameter DBEMM DNS DEEMM FMOC-Cl 
Corona needle voltage (V) 4000 4000 3500 4000 
Nebulizer gas pressure (psi) 60 50 50 60 
Drying gas flow (L min –1) 5 5 5 5 
Drying gas temp (ºC) 325 325 350 350 
Vaporizer gas temp (ºC) 350 350 350 400 
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Table 5. Analysis parameters (retention times (tR), m/z of precursor and product ions, 
collision energy (CE)) for alternating polarity mode LC-ESI-MS/MS analysis with 
QqQ. 
AA tR 
Positive ion mode Negative ion mode 
m/z CE (V) m/z CE (V) 
His 1.33 326 → 280 10 324→234** 10 
Arg 2.18 345 → 299 10 343→299 10 
Asn 2.37 303 → 257 10 301→257 10 
Gln 2.69 317 → 271 10 315→271 10 
Ser 2.79 276 → 230 10 274→184** 10 
Asp 3.13 326 → 280* 10 302→258 10 
Gly 4.10 246 → 200 10 244→154** 10 
Thr 4.25 290 → 244 10 288→244 5 
β-Ala 5.30 260 → 214 10 258→168** 5 
GABA 6.11 296 → 250* 10 272→182** 5 
α-Ala 6.33 260 → 214 10 258→168** 10 
Pro 6.40 286 → 240 10 284→194** 10 
Glu 6.43 318 → 272 10 316→272 5 
Tyr 6.86 352 → 306 20 350→306 10 
Met 7.59 320 → 274 10 318→274 10 
Val 7.78 288 → 242 10 286→242 5 
Trp 8.40 397 → 351 20 373→283** 10 
Orn 8.88 473 → 427 10 471→427 15 
Phe 8.98 336 → 290 10 334→290 5 
Ile 9.08 302 → 256 10 300→256 10 
Leu 9.34 302 → 256 10 300→256 10 
Lys 9.95 509 → 463* 10 485→441 15 
CE – collision energy 
* In positive ion mode: the precursor ion corresponds to [M+Na]+, unmarked corresponds to 
[M+H]+.** In negative ion mode: the product ion corresponds to [M-H-90]–, unmarked 
corresponds to [M-H-44]–. 
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3.5. Matrix influence evaluation methods 
3.5.1. Post-column infusion of pure derivatives  
[Papers III and V] 
Qualitative evaluation of ME was carried out using the post-column infusion 
experiment setup shown on Figure 2. The pure standard of the derivative was 
infused while the derivatized sample was chromatographically analyzed. The 
two solutions were mixed using a T-piece and introduced to the API source. 
The solutions of pure standard of the derivative (DEEMM or FMOC-Cl) at two 
concentration levels (low: 40 μg g–1; high: 1 mg g–1) were infused using a 
syringe pump (0.0033 mL min–1). Derivatized sample was analyzed 
chromatographically as blank sample does not exist. The chromatographic 
conditions described in section 3.4 were used for the chromatographic analysis. 
The MS/MS signal of the infused analyte was recorded. 
 
 
 
Figure 2. Setup of the post-column infusion experiments for LC-API-MS analysis 
involving derivatization.  
 
 
3.5.2. Post-derivatization spiking [Paper II] 
Three types of samples were prepared with DEEMM, DNS, FMOC-Cl and 
TAHS. First, a standard solution was derivatized and analyzed giving signal 
Astandard. Secondly, post-extraction spiking was carried out, meaning that blank 
matrix was spiked after sample preparation, but before derivatization and 
analysis resulted in signal A*matrix. Ratio of these signals yields ME%* (Eq. 2), 
which reflects both derivatization reaction yield and ionization ME, but not 
sample preparation recovery. 
 
 ࡹࡱ%∗ = ࡭࢓ࢇ࢚࢘࢏࢞∗࡭࢙࢚ࢇ࢔ࢊࢇ࢘ࢊ ∙ ૚૙૙% Equation 2 
 
Thirdly, a post-derivatization spiking was carried out by mixing separately 
derivatized standard solution and sample matrix giving signal Amatrix, which is 
unaffected by the derivatization reaction yield. The resultant ME estimation 
LC column:
derivatized sample is 
analyzed chromatographically
Syringe pump:
constant infusion of 
pure standard of derivative
API-MS
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dME% (Eq. 3) takes into account the ionization ME without the influence of 
derivatization yield. 
 
 ࢊࡹࡱ% = ࡭࢓ࢇ࢚࢘࢏࢞࡭࢙࢚ࢇ࢔ࢊࢇ࢘ࢊ ∙ ૚૙૙% Equation 3 
 
The relative yield of derivatization reaction can be calculated from the two ME 
values (Eq. 4).  
 
 ࢅ࢘ࢋ࢒ = ࡹࡱ%
∗
ࢊࡹࡱ% ∙ ૚૙૙% Equation 4 
 
 
3.5.3. Sample dilution approach for evaluating 
the ME [Papers III,IV,V] 
In order to assess the influence of sample dilution on the ME, analyte 
concentration was evaluated in the sample extract (C1) and its dilutions 
(C2…Cn), resulting in respective back-calculated concentrations C1(bc) …Cn(bc) 
(Eq. 5). 
 
 ࡯࢔(࢈ࢉ) = ࡯࢔ࢊ࢔ Equation 5 
 
where n represents each dilution and dn is the dilution factor calculated 
according to Eq. 6. 
 
 ࢊ = ࢓࢙ࢇ࢓࢖࢒ࢋ࢓࢚࢕࢚ࢇ࢒  Equation 6 
 
Where msample is the mass of sample taken for dilution and mtotal is the mass of 
extract after dilution.  
In order to characterize the derivatization reagents in the present work, the 
sample dilution influence on the back-calculated concentration was assessed 
using relative pooled standard deviation (RSD) of these concentrations (Eq. 7). 
 
 ࡾࡿࡰ =
ඨ(࡯૚(࢈ࢉ)ష࡯࢓ࢋࢇ࢔)૛శ ...    శ(࡯࢔(࢈ࢉ)ష࡯࢓ࢋࢇ࢔)૛
࢔
࡯࢓ࢋࢇ࢔     Equation 7 
 
This RSD describes the sample dilution influence on the quantitative analysis 
and a criterion was needed for making a decision about the presence of ME. 
SANTE validation guideline for pesticide analysis considers acceptable ME 
between 80–120% [100], which corresponds to RSD 16%. As there is no blank 
matrix available, the concentrations from undiluted and diluted samples were 
estimated and the RSD of concentrations (obtained from different dilution 
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factors) was chosen for this criterion. In addition, due to additional error from 
sample dilution and derivatization reaction reproducibility, the RSD above 20% 
was considered as indication of ME in the present work.  
The decision about matrix influence on the analysis was made for each 
analyte and the results of these experiments were divided into three main cases 
as shown on Figure 3. In the first case, RSD was below 20% meaning that the 
sample matrix did not have any effect on the analysis. When RSD was above 
20%, sample matrix influenced the analysis and two possible cases emerged. 
For cases where sample dilution eliminated matrix influence, a plateau of 
concentrations was reached (with RSD of at least 2 concentrations below 20%). 
The last case was when sample dilution decreased matrix influence, but a 
plateau of concentrations was not reached and extrapolative dilution approach 
[63] was used to evaluate the analyte’s concentration. This was based on 
extrapolating the graph of analyte concentration dependence on dilution factor 
to infinitely small dilution factor, which corresponds to the matrix-free solution. 
In order to do that, a linear range on the graph (with at least three points) was 
needed.[63] 
 
 
Figure 3. The analysis of results from sample dilution experiments. 
  
  
RSD
<20% (1) Sample matrix
does not affect the analysis
Concentration is presented 
as average of results from all 
dilutions
>20%
(2) Sample matrix affects 
analysis, but this 
is eliminated 
with sample dilution
Concentration is presented 
as average of concentration 
plateau (n>2, RSD<20%)  
(3) Sample matrix affects 
analysis, but 
is not eliminate 
with sample dilution
Extrapolative dilution 
approah is used for 
estimating the analyte 
concentration in indefinately 
diluted sample
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4. RESULTS AND DISCUSSION 
Matrix effect (ME), as a part of trueness, is one of the most important 
parameters for LC-MS method validation. Additionally, it can be used as a 
criterion for selecting derivatization reagents applied to LC-MS analysis. Since 
ME is not always evaluated for derivatization reagents and also new 
derivatization reagents have been developed in our work group, there are 
several reagents that need to be characterized and compared from ME point of 
view. Moreover, this information would be beneficial when designing new 
derivatization reagents aiming at sensitive and ME free LC-API-MS analysis.  
Present work covers characterization of six AA derivatization reagents using 
standard solutions [Paper I] and samples [Papers II, III, IV, V] including 
different experimental setups. Three of these derivatization reagents have been 
originally developed for UV or FL detection, but have also been applied to  
LC-API-MS analysis: DEEMM, DNS and FMOC-Cl. Remaining three were 
novel derivatization reagents, which have been designed specifically for 
sensitive LC-ESI-MS analysis. Firstly, a derivatization reagent published in 
literature TAHS [33], and secondly, DBEMM [4] and FOSF [Paper I], which 
have been designed and synthesized in-house. A set of seven AAs was chosen 
as model analytes to represent the wide variety of AA properties: Arg, Asp, Gly, 
β-Ala, Pro, Trp and Phe. DEEMM was also applied for analysis of 22 
AAs [Paper IV]. Applications covered 11 herbal extracts and five honeys.  
The main results of this research are discussed starting from the method 
optimization, leading to the analysis of samples, evaluation of ME and finishing 
with aspects to keep in mind when designing novel derivatization reagents. 
 
 
4.1. Method development  
Firstly, optimization of derivatization procedure is needed for ensuring the 
trueness of the analysis and, secondly, LC-API-MS analysis needs to be 
optimized in order to achieve the highest sensitivity. Prior to analysis of samples 
and evaluation of ME, additional optimization of derivatization reactions in 
samples, chromatographic separation, ionization source and mass spectrometric 
parameters was carried out. 
 
 
4.1.1. Optimization of derivatization procedures 
The yield of DEEMM and FMOC-Cl procedural standards [Paper III] 
For quantitative analysis using derivatization, there are in principle two types of 
standards which can be used: pure and procedural standards.[100] For AA 
analysis, the “pure standard” indicates the AA derivative without any additional 
compounds from the derivatization reaction, i.e. derivatization reagent itself, 
buffer salts or other components or products of the derivatization reaction. 
These can be either purchased or synthesized in-house. In the present work, the 
“procedural standard” stands for the standard solution of the derivative, which is 
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prepared by derivatization of the analyte standard solution. Hence, procedural 
standards can contain excess of the derivatization reagent, by-products of the 
derivatization reaction and other components necessary for the reaction, e.g. 
buffer components. Preparing standard solutions according to the same 
derivatization procedure as samples assures that the derivatization reaction yield 
is as similar as possible in standards and samples.  
In this work, pure standards of Gly-, β-Ala- and Phe-FMOC were obtained 
commercially and pure standards for respective DEEMM-derivatives were 
synthesized in-house. These were used for verifying the derivatization yield of 
DEEMM- and FMOC-Cl procedural standards in order to confirm the reliability 
of the quantitative analysis. The calibration graphs based on the UV signals of 
pure standards were used to calculate the AA concentrations detected in 
procedural standards. In this case, the UV detection has an advantage over  
API-MS, as it is not influenced by the ME. 
The average derivatization yield in standard solutions for three derivatives 
(n=6 for each derivative) was 109–117% for DEEMM-derivatives and 104–
116% for FMOC-derivatives. Derivatization yield higher than 100% could be 
explained by possible impurities in pure standards synthesized in-house or the 
degradation of pure derivatives. In general, the recovery was close to 100% with 
RSD below 11% for all cases, meaning that the derivatization yield is not a 
problem for procedural standards and concentration of the standard solutions 
can be used for quantification.  
In the present work, procedural standards were used for quantitative analysis 
with all the derivatization reagents. This is the general approach and especially 
relevant for MS detection, due to possible influences caused by other 
components in the derivatization mixture. Moreover, preparing the standard 
solutions as similarly as possible to the samples may compensate for some of 
the ME.[100] 
 
Optimization of derivatization reactions in samples [Papers I, II, III] 
The present work was focused on estimating the ME, but both recovery and ME 
contribute to the overall process efficiency of analysis. In order to avoid analyte 
loss during sample preparation, two sample types with high recovery sample 
preparation methods were chosen. First sample was honey, for which the 
sample preparation has high AA recovery and has been previously validated in 
our work group.[78,101] Second type of samples were green tea and herbal 
extracts, which were prepared using a simple extraction procedure without 
additional purification steps (section 3.3). 
The complexity of derivatization procedure is also of high importance for 
characterizing the derivatization reagents. As the analyte concentration and 
sample matrices vary to a great extent, it was important to optimize the 
derivatization procedure for samples. Contrary to standard solutions, samples 
contain other components beside analytes. If these can also react with the 
derivatization reagent, it might result in deficiency of the derivatization reagent 
or longer reaction time.  
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The optimal derivatization procedures for samples are summarized in 
experimental section 3.3. It was concluded that derivatization of samples with 
FMOC-Cl needed longer reaction time (30 min) compared to standard solutions. 
Sample derivatization with TAHS needed both higher concentration and longer 
reaction time (30 min) and derivatization with FOSF was carried out similar to 
TAHS. This shows that these derivatization procedures are not robust across 
different matrices and need to be optimized. The derivatization with DNS was 
suitable for selenoamino acid analysis in onion and was minimally modified for 
green tea and honey as lower DNS concentration was suitable for green tea.  
The original derivatization procedure with DEEMM was suitable for AA 
analysis in honey and selenoamino acid analysis in onion. In case of DEEMM, 
the derivatization reagent is added in large excess and reaction takes place 
immediately, only Pro needs reaction time of 24 h. For reducing the necessary 
sample size for derivatization from 1 mL as in Ref. [78] to 250 μL, the amount 
of all reagent solutions were proportionately reduced 4 times, without any effect 
to quantitative performance.  
DBEMM derivatization has been optimized for onion and honey. It reacts 
within minutes with most AAs, only Pro needed 2 h reaction time. The fast 
reaction and satisfactory repeatability for Pro has made it possible to use 
automated derivatization.[94]  
In general, derivatization procedures of DNS, DEEMM and DBEMM could be 
suitable for a wide range of applications. Moreover, as ending the reaction is not 
essential for DEEMM and DBEMM, these reactions are carried out in one step. 
 
 
4.1.2. Optimization of chromatographic analysis 
Chromatographic separation of the analyte peak from other matrix components 
can influence the analysis by causing ME. In order to minimize the possibility 
for such influences, it is important to achieve sufficient chromatographic 
separation. In the present work, the separation for seven AAs was aimed at, 
mostly so that the analytes would elute at a retention time far enough from the 
hold-up time in order to reduce the possible ME coming from early eluting 
compounds on RP, e.g. buffer components. 
Eluent composition and chromatographic separation was thoroughly optimized 
for LC-ESI-MS analysis with DEEMM, DNS, FMOC-Cl, TAHS and FOSF 
[Papers I and III]. Some additional optimization was needed due to using shorter 
chromatographic columns and evaluating suitability of LC eluent composition 
with LC-APCI-MS [Paper V].  
In addition to chromatographic separation, mobile phase composition influen-
ces the IE and optimal conditions can vary for different ionization sources. In this 
work, APCI was used for the first time for the analysis of AA derivatives of these 
reagents and a shorter column compared to previous experiments was used. 
Therefore, the optimization of mobile phase composition was needed and different 
combinations of two organic components (methanol and acetonitrile) and two 
aqueous phases (0.1% formic acid and ammonium acetate buffer (pH = 3.2)) were 
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tested. Acetonitrile was used for all derivatization reagents since it provided good 
chromatographic separation and the highest signal intensities (Figure 4).  
 
 
Figure 4. Comparison of organic solvent effect on signal intensity. Extracted ion chro-
matograms and APCI-MS spectra in case of acetonitrile and methanol as eluent 
components with ammonium acetate buffer for (a) DNS-β-Ala and (b) DEEMM-Arg. 
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Combinations of the two aqueous phase components (0.1% formic acid and 
ammonium acetate) with acetonitrile resulted in equal signals, but formic acid 
resulted in lower signals only for DBEMM. Consequently, the combination of 
acetonitrile and aqueous ammonium acetate buffer was used for further analyses 
with all the derivatization reagents. Detailed descriptions of the chromato-
graphic methods are presented in Experimental section 3.4 in Table 2, the 
retention times of seven AAs are presented in Table 3 and for 22 AAs with 
DEEMM in Table 5. 
 
 
4.1.3. LC-ESI-MS methods [Papers I–V] 
LC-ESI-MS experiments in this work were carried out on two different mass 
spectrometers, ion trap (XCT) [Papers I, II, III and V] and triple quadrupole 
(QqQ) types [Paper IV], which both used different LC systems. The m/z values 
of precursor and product ions used with XCT are in Table 4 in Experimental 
section 3.4.  
ESI-MS analysis in positive ion mode using XCT ion trap mass spectrometer 
was optimized and validated for analysis of seven AA standard solutions for 
DEEMM, FMOC-Cl, DNS, TAHS and FOSF [Paper I] and DBEMM [94]. 
DNS, TAHS and FOSF ionize through protonation and neutral AA is lost 
during fragmentation. Both protonated derivatives and Na-adducts were used as 
precursor ions for FMOC-Cl, DEEMM and DBEMM derivatives’ detection. 
The QqQ method development for DEEMM derivatization consisted of 
optimizing the ESI-MS parameters for 22 AAs in positive and negative ion 
mode. In positive ion mode, both protonated and Na-adducts of DEEMM-
derivatives were fragmented in order to find the optimal transition. The product 
ions were formed by loss of a neutral fragment of 46 amu from the 
derivatization reagent part (CH3CH2OH, M = 46 g mol–1). In some cases, in MS 
spectra Na-adduct yielded higher signal than protonated form, but fragments of 
protonated derivative resulted in higher MS/MS signal than fragments of the 
Na-adduct. As a result, Na-adducts were suitable precursor ions for Asp, GABA 
and Lys, while protonated derivatives were used for other AAs (Table 5, in 
section 3.4). In general, protonated precursor ions proved to be better suited for 
MS/MS analysis. This was attributed to the eluent composition, as the 
ammonium acetate additive contributes to the stability of Na-adduct signal [89], 
but formic acid was used in this work.  
In negative ion mode, LC-ESI-MS analysis of DEEMM-derivatives was 
carried out for the first time. Analysis with QqQ instrument used precursor ions 
which had formed via loss of proton ([M-H]–) and two kinds of product ions were 
produced during fragmentation. Firstly, carbon dioxide (CO2, M = 44 g mol–1) 
was lost from the AA part of the derivative resulting in product ion  
[M-H-44]–. This is characteristic to AA derivatives with other reagents, 
also.[87] Secondly, [M-H]– fragmented to give product ion [M-H-90]– cor-
responding to loss of both CO2 and ethanol (M=46 g mol–1). Product ion which 
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had lost only ethanol, like in positive ion mode, was not observed. The selection 
of precursor and product ions was carried out simultaneously with optimization 
of collision energies (Table 5 in section 3.4).  
 
 
4.1.4. LC-APCI-MS methods [Paper V] 
AA analysis with these derivatization reagents was carried out with LC-APCI-
MS for the first time. Due to the different ionization mechanisms compared to 
ESI, differences in the mass spectra can occur and the ionization and frag-
mentation needs to be determined. APCI-MS parameters were optimized for 
DEEMM, DBEMM, DNS, FMOC-Cl and FOSF derivatives of seven AAs. 
First, a novel derivatization reagent designed for LC-ESI-MS, FOSF, was 
tested, but a stable signal was not obtained with APCI. One reason could be the 
permanent positive charge on the derivatives, as similar problems have been 
seen before for permanently charged pesticides.[6] Therefore, FOSF was not 
considered a suitable derivatization reagent for APCI applications and could not 
be used for further experiments. 
DEEMM, DBEMM, FMOC-Cl and DNS proved to be suitable for APCI and 
m/z of the precursor and product ion of their derivatives are presented in Table 4 
in section 3.4. Protonated derivatives were observed for all of the analytes, e.g. 
DEEMM-β-Ala in Figure 5, and low signals of Na-adducts were observed for 
some DEEMM-derivatives (less than 8% of the signal of protonated form). The 
presence of Na-adducts shows that mixed mode ionization can occur in APCI 
and a part of the analyte molecules are ionized similarly as in ESI [28].  
 
 
 
Figure 5. Example of (a) ionization (MS) and (b) fragmentation (MS2) spectra of 
DEEMM- β -Ala in case of APCI (MS2 precursor ion m/z = 214). Note that Na-adduct is 
absent (m/z = 282) in MS spectrum (a). 
 
The protonated derivatives were used as precursor ions for all DBEMM-, DNS- 
and FMOC-derivatives. For DEEMM, the precursor ions were either protonated 
forms or the protonated derivatives, which had already undergone fragmentation 
by loss of ethanol fragment [M+H-46]+. The fragmentation of DEEMM-
derivatives in the ion source did not depend on the ion source parameters (e.g. 
vaporizer temperature) and was considered characteristic to APCI ionization. 
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Table 6. The values of lower limit of quantitation (LLOQ) in pmol on column. 
Amino 
acid 
DEEMM FMOC-Cl DNS DBEMM 
APCI ESI APCI ESI APCI ESI APCI ESI 
Arg - b 0.7 9.4 1.1 - b 1.3 5.9 0.4 
Asp 25 29 43 4.7 - a - a 5.2 1.7 
Gly 0.8 2.4 73 3.5 0.2 0.5 3.9 0.1 
β-Ala 0.9 17 38 0.6 8.2 0.3 2.0 0.1 
Pro - a - a 15 0.5 0.7 0.7 5.4 0.2 
Trp 1.6 1.6 2.4 0.3 1.6 2.7 2.7 0.3 
Phe 0.9 4.1 28 2.0 0.4 0.8 7.7 1.0 
a – stable signal was not obtained for both ESI and APCI 
b – stable signal was not obtained with APCI 
For all FMOC-derivatives, product ion with m/z 179 was used.[32] DNS 
derivatives ionized through protonation, but fragmentation differed depending 
on the analyte. All fragmentations are described in Table 4 in section 3.4. The 
signals of DNS-Asp and DEEMM-Pro [18], DEEMM-Arg and DNS-Arg were 
not obtained for quantitative analysis with APCI.  
Optimal ionization source and mass spectrometer parameters are necessary 
for sensitive analysis. Optimizing the parameters using constant infusion with 
effluent flow and the software of the instrument was used for pure derivatives of 
FMOC-Cl and DEEMM. For other reagents and analytes, the following APCI 
parameters were optimized by focusing on higher LC-MS signal: corona needle 
voltage, nebulizer gas pressure, drying gas flow, drying gas temperature and 
vaporizer gas temperature (Table 1 in section 3.4). Results showed that APCI is 
robust to changing the parameters and from these parameters, only drying gas 
influenced the results as lower value resulted in 2-times higher signals. The 
lower optimal drying gas flow could be connected with the additional vaporizer 
gas temperature compared to ESI source. 
The optimized parameters were used for evaluating the repeatability and 
lower limit of quantitation (LLOQ, expressed as the lowest concentration of 
linear calibration graph). The RSD of repeatability was under 15% for all 
detected analytes (n = 3, at concentration 50 pmol on column). From the LLOQ 
point of view (Table 6), ESI and APCI were comparable in case of DEEMM 
and DNS, LLOQ-s were more than 10 times lower with ESI for FMOC-Cl and 
DBEMM. An example of APCI spectra at LLOQ is presented on Figure 6. As a 
result, LC-APCI-MS methods suitable for quantitative analysis with four 
derivatization reagents were obtained: DEEMM, DBEMM, DNS and FMOC-Cl. 
These methods were used for further analysis in order to determine the matrix 
influence.  
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Figure 6. Examples of extracted ion chromatograms and APCI-MS2 spectra of β-Ala 
derivatives at LLOQ for (a) DEEMM, (b) DNS, (c) DBEMM and (d) FMOC-Cl. 
 
 
4.2. Evaluating ME – post-column infusion  
The characterization of derivatization reagents from ME point of view using 
several approaches was in the focus of this work. Firstly, qualitative evaluation 
of ME was carried out using post-column infusion experiments with green tea 
extract using ESI and APCI (described in section 3.5.1). Since this approach 
needs pure standard of the analyte, only DEEMM and FMOC-Cl were used as 
the pure derivatives of FMOC-Cl are commercially available and were 
synthesized in-house for DEEMM.  
This experiment also requires blank matrix, which is not available for AA 
analysis in green tea and a modification from the original post-column infusion 
experiment was used. Three types of derivatized samples were chromatographi-
cally analyzed, while the pure derivative was infused and its MS/MS signal was 
monitored. These samples were (1) derivatized deionized water as a matrix and 
analyte free sample, (2) derivatized AA standard solution and (3) derivatized 
green tea extract. Different samples were required in order to distinguish bet-
ween the origins of possible ME sources.  
The difference from original post-column infusion is that the infused analyte 
is also present in the chromatographically analyzed sample (samples 2 and 3). 
Therefore, the analyte’s signal from the chromatographically analyzed sample 
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adds to the signal of the infused analyte. This results in a peak on the extracted 
ion chromatogram at the retention time of the analyte rendering it impossible to 
evaluate the presence of ME in that point, which would be most valuable. 
Regardless, the general influence of ME on the analysis could still be 
characterized, especially if it is caused by the derivatization mixture compo-
nents. The results of post-column infusion experiments are discussed separately 
for ESI and APCI in the following chapters. 
 
 
4.2.1. Post-column infusion experiments  
with ESI-MS [Paper III] 
The post-column infusion experiments with ESI-MS showed that signal 
suppression was present for both FMOC- and DEEMM-derivatives. However, 
the nature and cause of ME were different. In case of FMOC-Cl, several signal 
suppression areas in the extracted ion chromatograms of infused FMOC-
derivatives were observed when samples (1)–(3) were chromatographically 
analyzed (Figure 7).  
Comparison of the result of all three infused FMOC-derivatives allowed to 
draw the following conclusions. Firstly, a suppression area was observed at the 
FMOC-histidine retention time meaning that FMOC-histidine was the cause of 
strong signal suppression in all the derivatized samples. Histidine is added to 
the reaction mixture (up to 1 mg mL–1 in the derivatized sample) in order to end 
the derivatization reaction and consequently it is present in all derivatized 
samples. Signal suppression was the strongest in analyte free sample (1) 
(Figure 7b*), as there are no analytes which could react with FMOC-Cl. 
Consequently, more FMOC-histidine is formed due to the higher concentration 
of unreacted FMOC-Cl compared to samples containing AAs (as in case of 
samples (2) and (3)).  
Secondly, additional suppression areas emerged when derivatized AA 
standard solution (2) and tea samples (3) were chromatographically analyzed 
(Figure 7b,c). The retention times of these suppression areas matched with the 
retention times of FMOC-derivatives of AAs in the samples (Figure 7a). It was 
concluded that other derivatized AAs and potentially also amines can cause ME 
for FMOC-derivatives. This is an important result, as derivatized matrix 
components can cause ME only during analysis of derivatized samples and 
these cannot be eliminated prior to the derivatization step. Furthermore, when 
comparing different infused FMOC-derivatives, it was observed that the signal 
of infused FMOC-Phe was less influenced than the signals of FMOC-Gly and  
-β-Ala, emphasizing that ME also depends on the structure of the AA part of the 
derivative.  
In conclusion, in case of FMOC-Cl derivatives, ME caused by the derivatized 
compounds is similar to any ME caused by the co-eluting compounds: it cannot 
be easily reduced or eliminated and it needs attention during method develop-
ment and validation. Additionally, the ME caused by other FMOC-derivatives 
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highlights the need for chromatographic separation in order to reduce the 
possible overlapping of the peaks causing ME with the analyte. Hence, chro-
matographic separation is essential even with MS detection. 
The results of post-column infusion experiments with DEEMM-β-Ala were 
significantly different from FMOC-derivatives. All of the chromatographically 
analyzed samples, (1)–(3), caused the signal suppression of the infused 
DEEMM-β-Ala starting from the hold-up time at 3 min until about 31 min 
(Figure 7d). The cause could be the borate buffer which is used for both  
FMOC-Cl and DEEMM derivatization. The signal enhancement of FMOC-
derivatives and suppression of DEEMM-derivatives due to the influence of 
borate buffer has been previously shown by our work group.[89,102] The 
considerable influence of borate buffer in case DEEMM could be due to 2.3 
times higher relative concentration of the borate buffer in the derivatized sample 
compared to FMOC-Cl. Differently from ME caused by FMOC-derivatives, this 
type of general ME can be eliminated or reduced, e.g. by changing the type of 
buffer used or diverting first minutes of the chromatographic run into waste 
instead of the ESI source so that the compounds causing the suppression would 
contaminate the source [89]. 
In order to obtain more information about the nature of these signal 
suppressions, post-column infusion experiments were carried out at different 
concentrations of the infused analyte. Results showed that ME depends on the 
concentration of the analyte: the higher the concentration of analyte, the less ME 
was present in case of both derivatization reagents. This is in line with literature 
results – the increased analyte-to-matrix ratio can decrease ME [103] due to 
competition for excess charge between analyte and matrix compounds [104].  
To sum it up, LC-ESI-MS analysis with both DEEMM- and FMOC-
derivatives was affected by the sample matrix. Compounds causing ME emerge 
during derivatization for both DEEMM- and FMOC-derivatives, but the cause 
of the ME was different. In case of FMOC-Cl, matrix components having amine 
functional group react with FMOC-Cl and those derivatives cause ME. In case 
of DEEMM derivatives, the signal suppression was caused by the derivatization 
mixture itself, rather than the sample matrix components.  
 
 
4.2.2. Post-column infusion experiments  
with APCI-MS [Paper V] 
The post-column infusion experiments with APCI presented different results 
compared to ESI. In case of FMOC-derivatives, only the signal suppression at 
the hold-up time and at the retention time of FMOC-His (Figure 7e) were 
observed. This means that the signal suppression due other AA derivatives in 
the analyzed sample was not an issue during APCI ionization or the con-
centrations in chromatographically analyzed samples were not high enough for 
causing ME in case of APCI.  
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In contrast to results of DEEMM-derivatives with ESI, the signal suppression 
due to borate buffer was not present for APCI (Figure 7f). This means that 
borate buffer can be used for APCI applications without the need for any 
techniques to reduce possible ME.  
 
 
Figure 7. Post-column infusion experiments with ESI and APCI. (a) UV-chromatogram 
of tea derivatized with FMOC-Cl. Analysis in ESI positive mode: (b) and (c) are 
extracted ion chromatograms of infused FMOC-Gly at two concentration levels of pure 
standard ((b) 40 μg g–1 and (c) 1 mg g–1) and (d) DEEMM β-Ala (40 μg g–1) while the 
effluent from chromatographic analysis of derivatized tea (with respective derivatization 
reagent) is added. Analysis in APCI positive mode: (e) infused FMOC-Phe and (f) 
infused DEEMM-β-Ala (43–48 μg g–1) when derivatized seven AA standard solution is 
analyzed chromatographically. In addition, (b)* shows FMOC-Gly signal when the 
derivatized water (grey) and sample (black) was analyzed. 
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Overall, the results of post-column infusion experiments show that there is a 
need for ME evaluation when using derivatization and it can depend on the 
derivatization reagents and ionization sources used. The qualitative experiments 
indicate that APCI is less prone to ME compared to ESI in case of FMOC-Cl 
and DEEMM. The advantage of the post-column infusion method is that it 
provides qualitative evaluation of ME over the entire chromatogram. However, 
quantitative evaluation of the matrix influence for each analyte is also needed, 
especially if the method is validated. 
 
 
4.3. Evaluating ME – 
derivatization and ionization ME [Paper II] 
The most widely used quantitative method for evaluation of ME is post-
extraction spiking. In case of derivatization, this method results in ME (ME%*), 
which includes both the derivatization reaction yield and the ionization ME. 
A new method was proposed by our work group – post-derivatization spiking – 
which allows quantitative evaluation of ME without being affected by the 
derivatization reaction yield. The derivatization ME (dME%) is calculated as 
the ratio of the signal of derivatized analyte spiked into derivatized matrix to the 
signal of the derivatized analyte in standard solution, so that the analyte 
concentrations in both samples are equal. From the two ME values, ME%* and 
dME%, the relative yield of derivatization reaction can be calculated using 
Eq. 2–4 in Experimental section 3.5.2. 
Comparison of four derivatization reagents (TAHS, DEEMM, DNS and 
FMOC-Cl) for analysis of two selenoamino acids in onion extract showed that 
the derivatization yield of FMOC-Cl, DNS and TAHS derivatization reactions 
were influenced by onion sample. In addition, no signal suppression was 
observed for TAHS and DEEMM. Although this ME evaluation method 
requires blank matrix and is therefore not suitable for all applications using 
derivatization, the results of two selenoamino acids emphasized the differences 
of derivatization reagents and the need for research from the ME point of view 
on a wider scale, i.e. more analytes, matrices and ion source variations.  
 
 
4.4. Evaluating ME – sample dilution  
Sample dilution experiments were applied for investigation of the matrix 
influence on analysis using derivatization, when neither blank matrix nor pure 
standards are available. The sample dilution influence was first evaluated on 
XCT mass spectrometer for seven AAs in green tea and honey samples with 
ESI and in green tea samples with APCI.  
Sample dilution experiments, described in Experimental section 3.5.3, 
resulted in three main cases and examples of AA derivatives are presented in 
Figure 8. First case (Figure 8a) shows that sample dilution had no effect on the 
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results obtained as dilution factor does not influence the final concentrations 
(RSD < 20%). The second case (Figure 8b), where RSD was initially above 
20% shows that after a certain dilution factor a plateau was reached, indicating 
that ME was eliminated (RSD < 20%). In the third case (Figure 8c), the RSD 
was above 20% and with every dilution a larger back-calculated concentration 
of the analyte was obtained, but no plateau was achieved, although the limit of 
quantitation has been reached and no further dilution is possible. In the latter 
case, the analyte concentration in the sample was evaluated using the 
extrapolative dilution approach [63] (Figure 8d).  
 
 
Figure 8. Examples of sample dilution approach for AA derivatives: (a) sample dilution 
had no significant influence on DNS-Pro in green tea; (b) sample dilution influenced 
analysis but a plateau of concentrations was reached for TAHS-Pro in honey; (c) strong 
ME on FMOC-β-Ala in honey and (d) extrapolative dilution approach was applied. 
 
 
4.4.1. ME during LC-ESI-MS analysis of green tea and 
honey [Papers III and V] 
For investigating the ME during LC-ESI-MS analysis, green tea and honey 
samples were derivatized with DEEMM, DNS, FMOC-Cl and TAHS and green 
tea with DBEMM and FOSF. The results with FOSF have not been published. 
Concentrations of seven AAs were determined in the original sample extract 
and five of its dilutions (up to 100-fold). Results showed that the concentrations 
obtained in original undiluted sample extract with different derivatization 
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reagents did not agree. Therefore, it was necessary to find conditions where the 
concentrations would agree and then evaluate the real concentrations in the 
samples. Adding SPE purification step to green tea extract sample preparation 
did not improve agreement between different reagents, implying that diluting 
the samples was necessary (Figure 9). The results are discussed below for all of 
the derivatization reagents.  
The analysis of green tea and honey (Figure 9a,b,c) showed that most DNS-
derivatives were affected by sample matrix in green tea, as RSD exceeded 50%, 
and was below 20% only for few AAs (Pro and Trp or Gly and β-Ala). Up to 
50-fold dilution was needed to eliminate ME and extrapolative dilution 
approach was used for Arg, Gly and Phe. Analysis of honey was less influenced 
by the dilutions and ME was eliminated by sample dilution (a plateau was 
reached) for all analytes. 
Analysis of green tea with FMOC-Cl was free from ME for Arg, Pro and 
Phe (RSD was below 20%), but extrapolative dilution approach was used for 
Asp, Gly and Phe. The matrix influence was stronger in honey and was 
eliminated by sample dilution for Asp and Trp derivatives, which means that 
extrapolative dilution approach was used for other derivatives. In comparison 
with DNS-derivatives, matrices appear to influence different AA derivatives to 
a different extent.  
The analysis using DEEMM was least affected by the sample matrix. 
Depending on samples and chromatographic separation, RSD was below 21% 
for all AA derivatives or up to 4-fold dilution was needed for eliminating any 
matrix influences. In general, less influence from sample matrix could be 
associated with the stronger retention of DEEMM-derivatives on RP-LC 
compared to other reagents. This leads to better chromatographic separation 
from matrix components. As a result, there are less matrix components, which 
could co-elute and cause ME. Note that the influence of borate buffer (section 
4.2.1) was accounted for as both the analyzed samples and the procedural 
standards used for calibration contained borate buffer. 
From the novel derivatization reagents, analysis of green tea with TAHS was 
free from ME (RSD below 20%) for Asp, Trp and Phe, a plateau was reached 
for β-Ala and extrapolative dilution approach was used for Arg, Gly and Pro. 
Similarly to FMOC-Cl, honey matrix (especially the most concentrated sample) 
had stronger influence and sample dilution was necessary for all AAs. Analysis 
of green tea with FOSF showed less ME compared to TAHS and sample 
dilution eliminated ME in all cases. The influence of green tea matrix on 
DBEMM analysis showed that Gly- and β-Ala-derivatives were not affected by 
the ME. Sample dilution was needed for eliminating ME in case of Trp- and 
Phe- (2-fold), Arg- and Pro- (4-fold) and Asp-derivatives (20-fold). 
In conclusion, amino acid derivatives differ markedly with respect to their 
susceptibility to matrix effects. Derivatization reagents exhibiting lower ME 
should be preferred for the applications where complex matrices are analyzed. 
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Figure 9. Dilution factors needed for elimination of ME in case of (a) honey and 
(b) green tea with ESI [Paper III] and green tea with (c) ESI and (d) APCI [Paper V]. 
The dilution factor 1 corresponds to undiluted sample (Eq. 6), “e” marks the cases when 
ME was not eliminated by sample dilution and extrapolative dilution approach was used 
for evaluating the analyte concentration, * – the analytes for which signals were not 
stable for quantitative analysis. 
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Table 7. Final AA concentrations in tea (μg g–1 in extract) and honey (μg g–1) using 
dilution experiments for LC-ESI-MS. 
 DEEMM DNS FMOC-Cl TAHS Average 
Te
a 
Arg 9.7 (15%) 7.7b (1) 11 (18%) 13b (0.84) 10 (21%) 
Asp 53.8 (17%) – 70b (0.97) 48 (9%) 57 (20%) 
Gly 0.85 (13%) 1.0b (0.79) 0.80b (0.99) 0.83b (0.82) 0.87 (10%) 
β-Ala 0.36 (7%) 0.42a (11%) 0.40a (17%) 6.8b (0.82) 2.0 (161%) 
Pro – 0.77 (18%) 3.2 (16%) 6.0a (14%) 3.3 (78%) 
Trp 5.9 (20%) 4.2 (14%) 4.6a (3%) 4.3 (22%) 4.7 (17%) 
Phe 8.0 (11%) 7.6b (1) 7.3 (14%) 6.6 (12%) 7.4 (8%) 
H
on
ey
 
Arg 5.3 (15%) 4.6 (17%) 5.5b (0.99) 6.2b (0.89) 5.4 (12%) 
Asp 11 (21%) – 3.8a (14%) 15a (9%) 10 (57%) 
Gly 3.9 (20%) 6.1 (12%) 4.9b (0.99) 4.9 b (0.93) 4.9 (21%) 
β-Ala 7.5 (20%) 7.5a (12%) 5.7b (0.94) 8.7a (10%) 7.4 (17%) 
Pro – 587a (21%) 529b (0.98) 408a (7%) 508 (18%) 
Trp 0.53 (18%) 0.52 (22%) 0.22a (4%) 0.43a (21%) 0.44 (32%) 
Phe 15 (19%) 16a (13%) 12b (0.95) 15b (0.99) 15 (10%) 
a Estimated using plateau of AA concentration at lower dilution factors (RSD is presented). 
b Estimated using extrapolative dilution approach (r2 is reported in parenthesis). 
All other concentrations were calculated as an average of all concentrations at all dilution 
factors (RSD is presented).  
 
Agreement of concentrations obtained with four derivatization reagents 
 [Paper III] 
It was concluded that different derivatization reagents have different ME for the 
same sample and dilutions are necessary for achieving higher trueness. In order 
to evaluate the success of eliminating the ME with sample dilution, agreement 
of the concentrations obtained with different ionization reagents was evaluated. 
The agreement between concentrations obtained with DEEMM, DNS, FMOC-Cl 
and TAHS (Table 7) was evaluated based on the RSD for each AA over all 
reagents for different matrices (Figure 10). The concentration of each AA in 
green tea extract was 0.87–57 μg g–1 and in honeys 0.44–508 μg g–1. 
For green tea, the results were within the RSD of 21% for Arg, Asp, Gly, Trp 
and Phe. For β-Ala better agreement was obtained (RSD = 11%) when results of 
TAHS were excluded. This stresses the fact that analytes at low concentrations 
could be more prone to ME [105] and that TAHS-derivatives are more 
influenced by the sample matrix. The agreement of Pro concentrations did not 
improve when excluding results obtained with different reagents. However, as 
Pro is a secondary amine and has reaction problems with DEEMM, this could 
be the possible cause for poor agreement of concentrations found in tea. 
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Figure 10. AA concentrations in green tea (μg g–1 in extract) and honey (μg g–1) from 
LC-ESI-MS analysis. Average concentrations are obtained over concentrations obtained 
with four derivatization reagents (n = 4, except for β-Ala in tea with TAHS). 
 
 
4.4.2. ME during LC-APCI-MS analysis of green tea [Paper V]  
In order to evaluate ME for LC-APCI-MS analysis, green tea sample and its 
four dilutions (up to 50-fold) with DEEMM, DNS, DBEMM and FMOC-Cl 
were analyzed.  
Results in Figure 9d show that some ME was present also for APCI analysis, 
but compared to ESI analysis, less dilution was needed to eliminate ME (final 
concentrations in Table 8). Similarly to results with ESI, concentrations 
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The agreement of results was similar for honey sample, where the RSD was 
below 22% for Arg, Gly, β-Ala, Pro and Phe, but was higher for Trp (32%) and 
Asp (57%). In general, analysis of honey with DEEMM and TAHS was less 
affected by the ME compared to the analysis using FMOC-Cl and DNS. The 
stronger ME for FMOC-Cl is in accordance with the post-column infusion 
experiments (chapter 4.2.1) which revealed several signal suppression areas for 
FMOC-derivatives. Concentrations obtained with FMOC-Cl were in many 
cases lower than with other reagents. This shows that although the analytes are 
chromatographically separated from each other, both matrices contain other 
AAs, amines or similar compounds which could cause ME.  
The sample dilution experiment with ESI showed that DEEMM-derivatives 
were least affected by the ME, as sample dilution was not necessary. Analysis 
using DNS was more affected in green tea and FMOC-Cl and TAHS overall, 
but especially in the concentrated honey samples. For the latter three, sample 
dilution and extrapolative dilution approach was needed in order to eliminate 
the ME.  
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obtained with DEEMM were also least influenced in case of APCI analysis. The 
RSD was below 20%, except for Asp analysis, which needed 2-fold dilution in 
order to eliminate the ME. This also confirms the results of post-column 
infusion experiments which did not reveal any signal suppression areas for 
DEEMM-derivatives with APCI (section 4.2.2).  
 
Table 8. The final concentrations of seven AAs in green tea extract (μg/g) with 
DEEMM, DNS, DBEMM and FMOC-Cl found using APCI and ESI (RSD < 20%, n = 
2–11)  
AA DEEMM FMOC-Cl DNS DBEMM 
APCI ESI APCI ESI APCI ESI APCI ESI 
Arg - a 28 27 25 - a 24 28 27 
Asp 129 126 109 93 - a - a 166 161 
Gly 0.9 1.0 - b 1,1 1.4 1.3 1.0 0.9 
β-Ala 1.1 1.0 - b 0,9 0.9 1.6 1.7 1.1 
Pro - a - a 9.6 6.5 13.3 9.5 10 8.7 
Trp 12 17 11 12 15 12 9.6 9.2 
Phe 28 36 28 29* 24 27 24 27 
a – signals not obtained 
b – signals below LLOQ 
* – concentration evaluated using the extrapolative dilution approach
Compared to ESI, FMOC- and DNS-derivatives were less influenced by sample 
matrix with APCI. FMOC-Arg, -Pro and -Trp were not affected by ME,  
FMOC-Phe needed 2-fold and FMOC-Asp needed 4-fold dilution in order to 
eliminate ME. The concentrations of Gly and β-Ala in green tea were below 
LoQ and could not be evaluated. Although less ME was present in case of 
APCI, ESI should be preferred for FMOC-Cl analysis from the sensitivity point 
of view. For DNS-β-Ala and -Trp, a 2-fold dilution was needed, but other 
analytes were free from ME.  
During analysis of DBEMM-derivatives with APCI, ME was similar to ESI. 
Gly- and β-Ala-derivatives did not have ME, 2-fold dilution was needed for 
Trp-, Phe-, Arg- and Pro-derivatives and 20-fold needed for Asp. As DBEMM 
is more sensitive compared to other derivatization reagents in ESI, and ME is 
eliminated with sample dilution, it could be considered suitable for both ESI 
and APCI.  
To conclude, the sample dilution experiments with APCI showed that the 
analyses with DEEMM and DNS were less affected than analysis with DBEMM 
and FMOC-Cl. This is similar to ESI, where DEEMM was less affected by ME 
than FMOC-Cl and DNS. Compared to ESI, APCI was in general less affected 
by ME, which means that less sample dilution is needed for elimination of the 
ME. This stresses the need to choose suitable derivatization reagent and 
ionization source for specific application. 
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4.4.3. Agreement of concentrations in green tea obtained 
with ESI and APCI 
As a result of sample dilution experiments, expected final concentrations were 
obtained with both ESI and APCI (Figure 11). This was achieved by eliminating 
ME by sample dilution or taking it into account using the extrapolative dilution 
approach. A comparison of these concentrations was carried out for seven AAs 
in green tea using DEEMM, DBEMM, DNS and FMOC-Cl. This comparison 
presents an additional confirmation of the reliability of the estimates of the AA 
concentrations with each derivatization reagent. 
The agreement of concentrations obtained with ESI and APCI was evaluated 
using two-tailed t-test at confidence level 95% for comparison of two means 
with equal variances (checked using F-test: two-tailed, confidence level 95%) 
for each analyte. The differences were not statistically significant, except for 
analyses of β-Ala with DBEMM and DNS. The problems with β-Ala have been 
mentioned earlier and the low concentration could be one reason or there might 
be sample components that co-elute with β-Ala and cause ME. Nevertheless, the 
agreement of concentrations shows that sample dilution has successfully 
eliminated ME in both ESI and APCI. 
Overall, the LC-APCI-MS methods provide quantitative analysis with 
DEEMM, DBEMM, DNS and FMOC-Cl. Matrix influence was successfully 
eliminated with sample dilution, improving the trueness of the method. 
 
  
 
Figure 11. The average concentrations of seven AAs in green tea extract (μg/g) found 
with four derivatization reagents using APCI and ESI. 
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4.5. Evaluating ME –  
dependence of ME on ESI polarity [Paper IV] 
The previous comparison of derivatization reagents was carried out in positive 
ionization mode as it was suitable for all of the chosen derivatives, including 
novel derivatization reagents for ESI-MS carrying permanent positive charge 
(TAHS, FOSF). It has been shown that there can be less ME in negative ion 
mode.[44] Thus, the dependence of ME on ionization polarity was examined for 
LC-ESI-MS analysis which is more prone to ME compared to APCI. DEEMM 
was chosen for analysis with alternating polarity ionization mode since the 
sample matrix does not affect the derivatization yield of DEEMM derivatization 
and only IE of the derivatives is influenced. This would additionally test the 
hypothesis that DEEMM-derivatives have less ME on a wider scale.  
The scope of ME investigation with DEEMM was widened in three aspects: 
analysis in the negative ion mode in addition to positive ion mode, 15 AAs were 
added to the previously analyzed seven AAs and, in addition to green tea and 
four honeys, 10 herbal extracts from Estonia were analyzed. The herbal extracts 
are used for recreational or healing purposes [106]: pine growth, yarrow, 
heather, linden (2 samples), chamomile (2 samples), cowslip, St. John’s wort 
and peppermint. The analysis was carried out simultaneously in positive and 
negative ion mode, so that the matrix influence would be comparable and not 
dependent on, for example, variations in sample, injection repeatability, ion 
source parameters or the ion source contamination. 
As the comparison of positive and negative ionization modes was carried out 
on QqQ mass spectrometer, a new LC-ESI-MS method for 22 AA DEEMM-
derivatives using alternating polarity ESI mode was developed. Therefore, 
method optimization (section 4.1.3) and validation was carried out in both 
ionization modes.  
 
 
4.5.1. Method validation 
Method validation involved estimating the repeatability (sample preparation, 
injection), linearity, limit of detection (LoD) and limit of quantitation (LoQ). 
The injection repeatability was below 15% (n = 3) and the repeatability of the 
sample preparation was below 18% (n = 3) for all AAs. The latter also takes 
into account the repeatability of the derivatization reaction. The values of within 
day repeatability were acceptable for ME studies, which were carried out based 
on each sample and its dilutions prepared on one day. 
The quantitative analysis requires estimating the linearity and linear range. 
As there were various matrix-analyte-concentration combinations, the working 
range spanned over 4 orders of magnitude. However, the data was not linear 
over the entire working range and two linear ranges were used instead, 
approximately 0.8–150 ng g–1 and 150–7000 ng g –1. 
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 Figure 12. Linearity of DEEMM-Lys (4–7000 ng g–1) shows higher signal in positive 
ion mode, but the S/N is (a) 14.4 in positive ion mode (C = 0.8 ng g–1) and (b) 66.6 in 
negative ion mode (C = 4 ng g–1). 
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The reason why positive ion mode is usually preferred is the higher signal 
intensity compared to negative ion mode. The LoD and LoQ values for 22 AAs 
in positive and negative ion modes are in Table 9. Although the signals were 
higher in positive ion mode, the signal-to-noise ratios (S/N) were higher in 
negative ion mode (see an example of linearity and S/N in case of DEEMM-Lys 
in Figure 12). The LoQ values were comparable in the two ionization modes for 
all AAs, being 3.0 to 32 fmol on column in positive ion mode and 4.5 to 
57 fmol on column in negative ion mode. 
In conclusion, the developed alternating polarity mode LC-ESI-MS method 
was suitable for quantitative analysis of 22 AAs in 11 herbal extracts and 
4 honeys using DEEMM-derivatization. As not all derivatization reagents allow 
analysis in both ion modes, it can be an advantage of DEEMM.  
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Table 9. Comparison of LoD and LoQ in positive and negative ion mode for analysis of 
22 DEEMM-derivatized AAs using alternating ion mode LC-ESI-MS  
 Positive ion mode Negative ion mode 
AA LoD (fmol) LoQ (fmol) LoD (fmol) LoQ (fmol) 
His 3.6 11 7.1 22 
Arg 6.0 18 6.3 19 
Asn 4.9 2.5 10 7.0 
Gln 7.9 24 12 37 
Ser 8.2 25 19 57 
Asp 7.3 22 4.8 15 
Gly 6.7 20 15 47 
Thr 9.3 28 3.4 10 
β-Ala 5.0 15 12 37 
GABA 4.4 13 8.6 26 
α-Ala 7.7 23 11 34 
Pro 10 32 9.0 27 
Glu 1.8 5.0 10 31 
Tyr 6.2 19 6.4 19 
Met 3.4 10 10 32 
Val 4.8 15 15 45 
Trp 1.0 3.1 1.5 4.5 
Orn 5.3 16 2.7 8.1 
Phe 4.7 14 5.7 17 
Ile 8.9 27 5.1 16 
Leu 5.8 18 6.8 20 
Lys 7.4 22 6.4 19 
 
4.5.2. Evaluation of ME  
The concentrations of 22 AAs were determined in three dilutions (dilution 
factors 1, 0.1 and 0.01) of 11 herbal extracts and four honeys using DEEMM 
derivatization. Analysis was carried out simultaneously in ESI positive and 
negative ion modes and results are discussed separately for each ion mode.  
ME in ESI positive ion mode for seven AAs in green tea and honey was 
previously discussed for DEEMM-derivatives in section 4.4.1. Analysis of 
22 AAs showed the presence of ME for some AAs (RSD above 20%), but in 
general, herbal extracts were less influenced by the sample matrix. The average 
RSD of AA concentrations in all herbal extracts was 10% (SD = 11%, n = 498), 
while it was 20% (SD = 17%, n = 133) in honeys (Figure 13). Compared to 
previous experiments, the reason for ME in these experiments could be 
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explained with a wider range of analytes, but also differences in samples, in 
chromatographic conditions and in the ion source.  
In honeys, ME could be observed for Asn, Asp, Gly, Thr, Val and Orn, and in 
some cases for Arg, α-Ala, Met, Trp, Leu and GABA. Due to the wide variety of 
herbal extracts, ME was observed in some cases with the RSD of 0%–47%, 
except for Val, for which the matrix influence was the strongest (RSD = 23%–
129% in pine growth, heather and linden2). In addition, ME affected the analysis 
of Asp, Gly, Val, Trp, Phe, Tyr and Leu derivatives in several herbal extracts. 
AAs most affected by ME were Asp, Val and Leu. This could mean that either 
matrix components co-elute with them or the IE of these derivatives is more 
easily influenced by the matrix components in positive ion mode.  
Negative ion mode was considerably less influenced by the ME. Taking into 
account all the matrices (herbal extracts and honeys), the average value of the 
RSD in the negative ion mode was 8% (SD = 7%, n = 641) (Figure 13). For 
honeys, the ME was present in honey1 and honey3 for Leu (RSD = 20%–76%) 
and in honey3 for Asp (RSD = 19%–28%), while ME was not present in herbal 
extracts.  
 
 
 
 
Figure 13. The dilution RSD values for 22 AAs in ESI positive (ESI+) and negative 
(ESI-) ion modes. The dashed line represents RSD = 20%, which is considered the 
threshold for presence of ME in this work.  
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The comparison of ionization modes shows that the negative ion mode is 
superior compared to positive ion mode in respect to the ME; at the same time 
the LoQ values are similar in the two modes. This proves that DEEMM in 
combination with the negative ion mode would be most suitable for analysis of 
complex matrices. 
 
Agreement of concentrations obtained with alternating polarity ionization mode 
ESI positive and negative ion modes had different ME and in order to evaluate 
the elimination of ME with sample dilution and its influence on the quantitative 
analysis, a comparison of concentrations of 22 AAs determined in 15 matrices 
in ESI positive and negative ion modes was carried out. Since ME was 
eliminated with sample dilution for positive ion mode, the concentrations from 
positive and negative ion mode agreed for most AAs.  
Although AA analysis has been previously carried out in honey [101], green 
tea [80] and chamomile [107], several extracts were analyzed for the first time. 
Results in Table 10 showed that the total free amino acid (TAA) concentrations 
in herbs were higher than in honeys. This is expected, as the concentrations are 
given with respect to honey and dry herbs, but honeys have high content of 
sugars and water. In addition, the relative content of essential AAs (Phe, Val, 
Thr, Trp, Met, Leu, Ile, Lys, His) from the TAA was 10%–19% in herbs and up 
to 73% in honey1.  
Figure 14. Total free AA concentration in herb and honey samples (mg kg–1).  
 
40000
20000
25000
30000
35000
nc
en
tr
at
io
n 
(m
g 
kg
-1
)
0
5000
10000
15000
To
ta
l a
m
in
o 
ac
id
 c
on
essential amino acids
Ta
bl
e 
10
. T
he
 c
on
ce
nt
ra
tio
ns
 o
f 2
2 
A
A
s i
n 
he
rb
al
 e
xt
ra
ct
s a
nd
 h
on
ey
s (
ne
ga
tiv
e 
io
n 
m
od
e)
 w
ith
 R
SD
 o
f c
on
ce
nt
ra
tio
ns
 fr
om
 th
re
e 
di
lu
tio
ns
 in
 
po
si
tiv
e 
an
d 
ne
ga
tiv
e 
io
n 
m
od
e.
 M
E 
w
as
 c
on
si
de
re
d 
pr
es
en
t w
he
n 
th
e 
R
SD
 w
as
 a
bo
ve
 2
0%
 (m
ar
ke
d 
w
ith
 g
re
y 
ba
ck
gr
ou
nd
). 
a 
– 
co
nc
en
tra
tio
n 
in
 th
e 
sa
m
pl
e 
w
as
 b
el
ow
 L
oQ
; b
 –
 c
on
ce
nt
ra
tio
n 
in
 th
e 
sa
m
pl
e 
w
as
 o
ut
si
de
 th
e 
ca
lib
ra
tio
n 
ra
ng
e;
 N
A
 –
 th
e 
R
SD
 c
ou
ld
 n
ot
 b
e 
es
tim
at
ed
 
pi
ne
 g
ro
w
th
 
ya
rr
ow
 
he
at
he
r 
lin
de
n1
 
lin
de
n2
 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
) 
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
H
is
 
15
4
5%
12
%
19
6
7%
13
%
14
 
3%
6%
11
1
6%
7%
85
2%
1%
 
A
rg
 
11
98
9%
11
%
22
4
7%
16
%
51
 
10
%
7%
80
8%
2%
48
2%
5%
 
A
sn
 
36
20
0%
5%
19
80
35
%
10
%
12
3 
15
%
16
%
30
12
N
A
N
A
38
9
7%
11
%
 
G
ln
 
14
81
10
%
15
%
15
95
10
%
20
%
21
0 
4%
18
%
77
0
9%
7%
10
08
6%
4%
 
Se
r 
32
7
20
%
10
%
45
5
24
%
8%
41
 
3%
20
%
39
3
19
%
9%
10
8
7%
11
%
 
A
sp
 
47
16
%
19
%
26
0
34
%
12
%
31
 
21
%
12
%
31
8
33
%
6%
77
10
%
5%
 
G
ly
 
58
24
%
1%
52
8%
14
%
22
 
2%
15
%
41
3%
5%
23
17
%
1%
 
Th
r 
29
4
13
%
15
%
29
2
9%
19
%
47
 
4%
4%
11
3
10
%
13
%
13
5
9%
8%
 
β-A
la
 
54
4%
10
%
53
23
%
10
%
6.
4 
2%
12
%
29
3%
8%
23
4%
1%
 
G
A
B
A
 
11
22
7%
8%
82
1
9%
15
%
38
0 
10
%
15
%
64
3
3%
16
%
39
4
2%
3%
 
α-A
la
 
16
6
21
%
17
%
28
9
19
%
14
%
12
7 
20
%
1%
23
4
14
%
10
%
26
6
3%
5%
 
Pr
o 
11
45
6%
18
%
21
34
11
%
11
%
69
 
12
%
7%
12
81
N
A
N
A
99
7
5%
6%
 
G
lu
 
5.
4
N
A
N
A
2.
7
N
A
N
A
 - 
a 
N
A
N
A
3.
1
N
A
N
A
N
A
13
%
N
A
 
Ty
r 
17
7
12
%
9%
16
5
19
%
14
%
22
 
21
%
18
%
16
1
17
%
9%
10
3
28
%
0%
 
M
et
 
0.
7
N
A
N
A
22
25
%
5%
0.
3 
N
A
N
A
0.
4
N
A
N
A
1.
1
20
%
6%
 
V
al
 
23
1
10
0%
11
%
36
3
0%
15
%
34
 
12
9%
4%
20
5
33
%
4%
12
0
49
%
8%
 
Tr
p 
79
26
%
1%
14
0
28
%
19
%
9 
N
A
N
A
43
37
%
15
%
71
19
%
5%
 
O
rn
 
78
22
%
9%
5.
9
4%
9%
3.
0 
13
%
0%
3.
0
7%
6%
2.
1
15
%
10
%
 
Ph
e 
13
0
27
%
10
%
22
4
26
%
15
%
14
 
5%
4%
66
4
23
%
10
%
34
0
11
%
0%
 
Ile
 
76
12
%
6%
23
1
26
%
7%
26
 
12
%
5%
69
7%
8%
90
8%
14
%
 
Le
u 
83
27
%
20
%
20
2
23
%
17
%
18
 
1%
9%
14
2
16
%
7%
85
5%
6%
 
Ly
s 
26
9
9%
7%
14
5
3%
11
%
12
 
11
%
15
%
26
2%
5%
48
4%
4%
 
54 
 ch
am
om
ile
1 
ch
am
om
ile
2 
co
w
sl
ip
 
St
. J
oh
n’
s w
or
t 
pe
pp
er
m
in
t 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
) 
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
H
is
 
13
8
5%
16
%
43
1
7%
3%
11
8 
5%
5%
18
0
5%
2%
57
10
%
9%
 
A
rg
 
17
1
3%
20
%
68
4
0%
2%
69
2 
12
%
7%
20
3
6%
11
%
89
15
%
7%
 
A
sn
 
47
6
9%
16
%
43
34
11
%
8%
18
18
 
15
%
9%
61
6
7%
1%
47
9
8%
2%
 
G
ln
 
28
37
3%
19
%
11
62
9
8%
10
%
10
52
2 
1%
13
%
76
15
0%
8%
13
44
6%
3%
 
Se
r 
47
4
10
%
1%
11
13
6%
6%
30
9 
13
%
11
%
48
4
0%
2%
10
4
3%
9%
 
A
sp
  
29
2
9%
13
%
97
7
8%
2%
30
2 
36
%
6%
79
15
%
1%
27
1
21
%
2%
 
G
ly
 
12
3
3%
17
%
15
8
13
%
8%
53
 
19
%
9%
44
3%
7%
34
8%
10
%
 
Th
r 
28
2
1%
20
%
64
8
0%
0%
18
3 
5%
5%
39
6
6%
9%
11
4
11
%
5%
 
β-A
la
 
65
7%
7%
10
9
8%
8%
20
 
9%
9%
29
2%
12
%
30
3%
15
%
 
G
A
B
A
 
16
48
5%
17
%
16
84
5%
0%
13
24
 
0%
11
%
15
49
4%
3%
62
3
6%
15
%
 
α-A
la
 
73
9
9%
20
%
67
5
3%
10
%
39
6 
7%
12
%
50
3
7%
12
%
32
5
11
%
14
%
 
Pr
o 
16
00
10
%
9%
76
20
9%
2%
67
8 
1%
16
%
14
86
N
A
N
A
63
4
3%
14
%
 
G
lu
 
 - 
a
N
A
N
A
8.
3
19
%
N
A
 - 
a 
N
A
N
A
2.
6
N
A
N
A
2.
6
N
A
N
A
 
Ty
r 
19
5
9%
15
%
22
8
5%
9%
75
 
10
%
12
%
16
0
17
%
1%
67
8%
2%
 
M
et
 
3
4%
14
%
48
7%
6%
1.
5 
N
A
N
A
4.
1
14
%
1%
1.
1
N
A
N
A
 
V
al
 
35
8
2%
14
%
11
03
3%
1%
39
1 
56
%
4%
38
9
12
%
10
%
19
0
79
%
2%
 
Tr
p 
91
11
%
3%
41
0
8%
5%
15
6 
30
%
9%
11
8
47
%
5%
77
33
%
7%
 
O
rn
 
8
12
%
10
%
15
11
%
4%
9.
1 
17
%
6%
5.
5
11
%
1%
12
1%
20
%
 
Ph
e 
16
9
12
%
18
%
71
8
2%
1%
20
5 
6%
8%
20
8
15
%
4%
14
6
4%
15
%
 
Ile
 
38
9
5%
7%
70
7
8%
9%
33
2 
10
%
1%
13
6
10
%
6%
17
8
13
%
8%
 
Le
u 
25
1
8%
16
%
63
1
1%
1%
26
0 
17
%
8%
16
5
4%
5%
11
7
2%
8%
 
Ly
s 
29
1
8%
14
%
55
5
1%
0%
12
6 
6%
2%
96
12
%
0%
48
17
%
6%
 
 
 
55 
Ta
bl
e 
10
. C
o
n
ti
n
u
ed
 
gr
ee
n 
te
a 
ho
ne
y1
 
ho
ne
y2
 
ho
ne
y3
 
ho
ne
y4
 
 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
) 
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
C
   
(m
g 
kg
-1
)
R
SD
 
(p
os
) 
R
SD
 
(n
eg
) 
H
is
 
58
15
%
4%
3.
2
7%
5%
3.
7 
8%
9%
4.
5
13
%
2%
4.
4
14
%
18
%
 
A
rg
 
28
9
13
%
7%
4.
2
16
%
8%
2.
9 
19
%
10
%
13
23
%
14
%
6.
0
13
%
10
%
 
A
sn
 
55
5
3%
16
%
3.
7
48
%
5%
9.
4 
36
%
4%
18
49
%
6%
8.
0
54
%
9%
 
G
ln
 
41
17
6%
2%
1.
9
4%
13
%
6.
7 
7%
0%
36
15
%
3%
8.
2
8%
13
%
 
Se
r 
32
5
10
%
12
%
4.
4
9%
15
%
4.
7 
16
%
5%
9.
7
15
%
2%
8.
2
12
%
14
%
 
A
sp
  
17
68
6%
5%
7.
8
20
%
6%
11
 
27
%
7%
9.
5
48
%
28
%
13
10
1%
2%
 
G
ly
 
16
9%
8%
8.
0
16
%
16
%
4.
5 
23
%
9%
9.
5
22
%
9%
7.
4
22
%
10
%
 
Th
r 
16
2
7%
13
%
1.
7
34
%
20
%
2.
8 
24
%
13
%
6.
9
11
%
17
%
5.
8
18
%
18
%
 
β-A
la
 
16
31
%
15
%
12
19
%
4%
10
 
7%
1%
13
4%
10
%
9.
2
2%
13
%
 
G
A
B
A
 
24
4
3%
2%
5.
6
8%
9%
3.
7 
6%
10
%
11
1%
16
%
7.
4
39
%
9%
 
α-A
la
 
18
6
7%
8%
8.
6
30
%
8%
17
 
15
%
15
%
12
17
%
7%
10
13
%
11
%
 
Pr
o 
13
7
17
%
4%
 - 
b
N
A
N
A
59
3 
N
A
N
A
90
1
N
A
N
A
40
4
N
A
N
A
 
G
lu
 
2.
4
19
%
20
%
 - 
a
N
A
N
A
 - 
a 
N
A
N
A
 - 
a
N
A
N
A
4.
0
N
A
N
A
 
Ty
r 
14
6
24
%
10
%
21
3
N
A
N
A
10
 
14
%
11
%
16
15
%
16
%
7.
4
12
%
10
%
 
M
et
 
0.
8
16
%
N
A
0.
02
N
A
N
A
31
4 
16
%
10
%
0.
3
19
%
3%
0.
7
37
%
10
%
 
V
al
 
19
1
25
%
14
%
4.
7
79
%
12
%
4.
5 
81
%
6%
8.
6
61
%
6%
6.
9
70
%
3%
 
Tr
p 
18
8
10
%
13
%
0.
04
N
A
N
A
0.
04
 
N
A
N
A
2.
3
6%
11
%
0.
02
6%
12
%
 
O
rn
 
2.
5
7%
19
%
1.
0
23
%
16
%
0.
8 
42
%
11
%
1.
0
27
%
20
%
0.
6
44
%
7%
 
Ph
e 
22
6
5%
9%
70
5
N
A
N
A
30
 
20
%
7%
71
N
A
N
A
28
12
%
18
%
 
Ile
 
15
7
9%
13
%
3.
4
21
%
6%
18
1 
N
A
N
A
27
2%
6%
8.
0
14
%
7%
 
Le
u 
11
4
11
%
19
%
3.
5
22
%
42
%
4.
7 
5%
14
%
7.
3
11
%
44
%
5.
7
19
%
5%
 
Ly
s 
17
1
10
%
9%
16
1%
8%
14
 
0%
8%
22
6%
10
%
19
8%
11
%
 
 
56 
Ta
bl
e 
10
. C
o
n
ti
n
u
ed
57 
4.6. Principles for designing novel derivatization reagents 
Based on previously discussed results, conclusions can be made about the 
suitability of these derivatization reagents for LC-MS analysis. There are 
several aspects to keep in mind when choosing a suitable derivatization reagent 
for an application or designing a new one: reaction with the analyte, com-
patibility with the ion source and mode, ionization efficiency of derivatives, 
matrix influence, etc. The characteristics from the results obtained in this work 
and in our work group have been summed up for six derivatization reagents 
(Table 11 and Table 12). Following, the main conclusions drawn about designing 
novel derivatization reagents are discussed. 
The structure of the derivatization reagent determines the ionization 
efficiency and fragmentation patterns, which are important for sensitive MS 
detection. From the sensitivity point of view, the logIE values have been the 
starting point when designing novel derivatization reagents for LC-MS analysis. 
For example, logIE values indicate that one aspect providing high IE and low 
LoD is the permanent charge on the analyte. However, results show that once 
the chromatographic system is added and analysis of samples is carried out, 
such derivatives might not be superior to other reagents and similar LoQ values 
can be obtained for reagents without permanent charge as well. Moreover, due 
to the permanent positive charge, novel reagents are not suitable for analysis in 
negative ion mode, which has been proved to be less influenced by ME and is 
superior when analysis with minimal ME is sought. Therefore, the other aspect 
from logIE scales, the large non-polar structure, like DBEMM, should be suitable 
for derivatization reagents. Structure wise, structures similar to DEEMM-
derivatives provide sensitivity that was similar in both positive and negative ion 
modes.  
Comparison of different ion sources showed that during method optimization 
it is important to re-evaluate the precursor and product ions. Some derivatives 
ionize via both protonation and adduct formation and the latter depends on the 
ionization source and instrument, as well as eluent composition. From the 
reagents used, DEEMM, DBEMM, DNS and FMOC-Cl, derivatives are suitable 
for both ESI and APCI ionization. ESI ionization can produce both protonated 
ions, as well as Na-adducts, while in APCI, protonation was observed for 
DEEMM, FMOC-Cl, DNS and DBEMM.  
When a design of sensitive APCI derivatization reagents is targeted, then 
structures similar to DEEMM and DNS serve as useful starting points as their 
derivatives provided APCI LLoQ values comparable to ESI. In addition, FOSF 
did not provide stable signal in APCI possibly due to the permanent positive 
charge of the derivatives, which was designed for enhancing IE in ESI. Con-
sequently, non-charged derivatives should be preferred for APCI reagents. 
Characteristic transition is one of the aims of derivatization for LC-MS. For 
most of the derivatives studied (TAHS, FMOC-Cl, FOSF and DNS), the product 
ion is the same for all analytes and depends only on the derivatization reagent. On 
the other hand, DEEMM- and DBEMM-derivatives differ from others as the 
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same neutral fragment is lost during fragmentation, resulting in characteristic 
product ions for each analyte. As the fragmentation involves derivatization 
reagent moiety of the molecule, all the DEEMM-derivatives have similar MS/MS 
fragmentation parameters. This would considerably reduce time required for MS 
parameter optimization. It also enables use of neutral loss scan mode for non-
target screening of amino group containing compounds.  
From method validation point of view, accuracy (trueness and precision) is 
often one of the most important parameter that needs to be evaluated. In turn, 
ME is the main component of trueness evaluation for LC-API-MS analysis. 
From the ME point of view, both endogenous and exogenous compounds can 
affect the ionization efficiency, and in addition, new compounds forming during 
the derivatization reaction should be considered. On the one hand, ME caused 
by the exogenous compounds (e.g. derivatization reaction components) should 
be determined already in the method development step and the cause of ME 
might be eliminated by choosing the suitable components, e.g. buffer 
components. On the other hand, eliminating endogenous compounds, including 
derivatives of non-analytes formed during derivatization, can be more complex. 
This emphasizes the need for good chromatographic separation even if MS 
detection is used, and here the derivatives without permanent positive charge 
(DBEMM, FMOC-Cl, DEEMM and DNS) have an advantage.  
Regardless of the cause of ME, different derivatization reagents can be 
differently affected by ME. In ESI, derivatives of DEEMM and DBEMM have 
the least ME, followed by FMOC-Cl and DNS depending on the matrix. TAHS, 
designed for high ionization efficiency and carrying a positive charge, was 
affected by ME the most. In APCI, less ME was present for all the derivati-
zation reagents, while DEEMM and DNS were least affected by the ME, 
followed by DBEMM and FMOC-Cl.  
It was demonstrated that the matrix influence depends also on the analyte 
and not only the derivatization reagent. This could be connected to the retention 
time and co-eluting components causing the ME, but also to the structure of the 
AA. Therefore, it is desirable that the structure of the derivatization reagent 
dominates and allows robust and ME free analysis. Based on these results it can 
be concluded that the derivatization reagents designed for APCI positive and/or 
negative ion detection should be targeted for robust and ME-free analysis.  
While striving towards higher IE, chemical aspect – yield of derivatization 
reaction – must also be kept in mind. All studied reagents react rapidly with 
amines with the only significant exception of Pro reactions with DEEMM and 
DBEMM. Compared to standard solutions, derivatization procedures used for 
FMOC-Cl and TAHS and FOSF needed modification for more complex 
samples, and DNS reaction was also affected by the sample matrix. At the same 
time, the derivatization reaction yield of DEEMM proved to be unaffected by 
the sample matrix. This stresses that optimizing derivatization procedure with 
standard solutions is not sufficient. Therefore, reactive moieties of derivati-
zation reagents similar to those of DEEMM and DBEMM are promising 
candidates for application with new derivatization reagents. 
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In addition, from practical point of view, automatization of the derivatization 
procedure can save resources (e.g. reagents, time, labor). Moreover, DBEMM 
[94], FMOC-Cl [108] and DNS [109] have already been used with automated 
derivatization procedure. Addition of a specific reagent to eliminate excess of 
derivatization reagent is an inconvenient step especially for automated derivati-
zation. Preferably, novel derivatization systems shall be developed to not 
require stopping stage. 
In conclusion, using the logIE scale as the starting point for developing 
novel derivatization reagents for LC-API-MS is suitable, when also taking into 
account other aspects besides IE, i.e. derivatization reaction, chromatographic 
retention, matrix influence on the reaction and on the IE, ionization and frag-
mentation mechanisms. Possible causes of ME from derivatization reaction 
should be monitored from the beginning of the method development. When 
analyte free matrix and pure standards are not available, then sample dilution 
method can be used for evaluating ME of derivatization LC-MS.  
 
 
 
Ta
bl
e 
11
. S
um
m
ar
y 
of
 c
om
pa
ris
on
 o
f s
ix
 d
er
iv
at
iz
at
io
n 
re
ag
en
ts
 fo
r L
C
-A
PI
-M
S 
an
al
ys
is
: d
er
iv
at
iz
at
io
n 
re
ac
tio
n 
an
d 
ch
ro
m
at
og
ra
ph
y 
R
ea
ge
nt
 
A
na
ly
te
s 
Sa
m
pl
e 
si
ze
 
R
ea
ge
nt
s a
dd
ed
 to
 sa
m
pl
e 
R
ea
ct
io
n 
tim
e 
M
at
ri
x 
in
flu
en
ce
 o
n 
re
ac
tio
n 
yi
el
d1
M
de
ri
va
tiv
e 
[g
/m
ol
] 
R
et
en
tio
n 
in
 R
PL
C
 
Lo
Q
 [f
m
ol
 o
n 
co
lu
m
n]
 
[P
ap
er
 I]
 
D
E
E
M
M
 
pr
im
ar
y 
an
d 
se
co
nd
ar
y 
am
in
es
, 
*P
ro
 
25
0 
μl 
 
1)
 3
75
 μl
 D
EE
M
M
 (1
:5
0 
so
lu
tio
n 
in
 M
eO
H
) 
2)
 8
75
 μl
 b
or
at
e 
bu
ff
er
 (0
.7
5 
M
, p
H
=9
) 
 
fe
w
 m
in
ut
es
,  
24
 h
 fo
r P
ro
 
– 
A
H
+1
70
 
**
 
**
 
D
B
E
M
M
 
pr
im
ar
y 
an
d 
se
co
nd
ar
y 
am
in
es
 
50
 μl
  
1)
 3
00
 μl
 D
B
EM
M
 (1
:1
50
 in
 is
op
ro
pa
no
l) 
2)
 2
00
 μl
 H
FI
P 
(0
.5
6 
M
, p
H
=9
.0
)  
fe
w
 m
in
ut
es
,  
2h
 fo
r P
ro
 
N
/A
 
A
H
+2
94
 
**
* 
**
* 
[9
4]
 
D
N
S 
pr
im
ar
y 
an
d 
se
co
nd
ar
y 
am
in
es
, 
*A
sp
 
10
0 
μl 
1)
 2
0 
μl 
N
aO
H
 (2
 M
) 
2)
 5
00
 μl
 D
N
S 
so
lu
tio
n 
(5
 m
g 
m
L−
1 
fo
r t
ea
 
an
d 
10
 m
g 
m
L−
1  f
or
 h
on
ey
) 
3)
 re
ac
tio
n 
is
 e
nd
ed
 w
ith
 1
0 
μl 
co
nc
 N
H
4O
H
  
45
 m
in
  
(in
 th
e 
da
rk
 a
t 4
 ºC
) 
 
+ 
A
H
+2
33
 
**
 
* 
FM
O
C
-C
l 
pr
im
ar
y 
an
d 
se
co
nd
ar
y 
am
in
es
 
30
0 
μl 
1)
 3
00
 μl
 b
or
at
e 
bu
ff
er
 (0
.7
5 
M
, p
H
=9
) 
2)
 3
00
 μl
 F
M
O
C
-C
l (
1 
m
g 
m
L–
1 )
 
3)
 3
00
 μl
 H
is
 (4
 m
g 
m
L–
1 )
  
30
 m
in
 fo
r t
ea
 a
nd
 
ho
ne
y 
+ 
A
H
+2
22
 
**
* 
* 
TA
H
S 
pr
im
ar
y 
an
d 
se
co
nd
ar
y 
am
in
es
 
10
 μl
 
1)
 3
0 
μl 
bo
ra
te
 b
uf
fe
r (
0.
2 
M
, p
H
= 
8.
8)
 
2)
 2
0 
μl 
TA
H
S 
(2
0 
m
g 
m
L–
1  i
n 
ac
et
on
itr
ile
) 
3)
 re
ac
tio
n 
is
 e
nd
ed
 w
ith
 2
00
 μL
 a
ce
tic
 a
ci
d 
(0
.2
%
) 
30
 m
in
 
+ 
A
H
+1
77
 
* 
**
 
FO
SF
 
pr
im
ar
y 
an
d 
se
co
nd
ar
y 
am
in
es
 
10
 μl
 
1)
 3
0 
μl 
bo
ra
te
 b
uf
fe
r (
0.
2 
M
, p
H
= 
8.
8)
 
2)
 2
0 
μl 
FO
SF
 (2
0 
m
g 
m
L–
1  i
n 
ac
et
on
itr
ile
) 
3)
 re
ac
tio
n 
is
 e
nd
ed
 w
ith
 2
00
 μL
 a
ce
tic
 a
ci
d 
(0
.2
%
) 
30
 m
in
 
N
/A
 
A
H
+2
98
 
* 
**
 
1  “
+“
  p
ro
bl
em
, “
–“
 n
ot
 a
 p
ro
bl
em
;  
**
*s
tro
ng
 o
r g
oo
d,
 *
* 
m
ed
iu
m
, *
po
or
 
 
 
60 
Ta
bl
e 
12
. S
um
m
ar
y 
of
 c
om
pa
ris
on
 o
f s
ix
 d
er
iv
at
iz
at
io
n 
re
ag
en
ts
 fo
r L
C
-A
PI
-M
S 
an
al
ys
is
: p
os
iti
ve
 io
n 
m
od
e.
 
R
ea
ge
nt
 
ES
I  
A
PC
I  
Io
ni
za
tio
n 
Fr
ag
-
m
en
ta
tio
n
lo
gI
E 
(M
eO
H
) 
[9
5]
 
lo
gI
E 
(M
eC
N
) 
[9
5]
 
R
es
is-
ta
nc
e 
to
 M
Ea
 
Io
ni
za
tio
n 
Fr
ag
m
en
ta
tio
n
lo
gI
E 
(M
eO
H
) [
95
]
lo
gI
E 
(M
eC
N
) 
[9
5]
 
R
es
is-
ta
nc
e 
to
 M
E 
D
E
E
M
M
 
[M
+H
]+
, 
[M
+N
a]
+ 
 –
Et
O
H
,  
–2
Et
O
H
 
D
EE
M
M
 2
.3
6,
  
Ph
e-
D
EE
M
M
 3
.7
9,
 
G
ly
-D
EE
M
M
 3
.3
6 
D
EE
M
M
 2
.0
4,
  
Ph
e-
D
EE
M
M
 0
.7
8,
 
G
ly
-D
EE
M
M
 2
.7
3 
**
* 
[M
+H
]+
 
[M
+H
–4
6]
+
–2
Et
O
H
,  
–H
2O
, –
C
O
2 
D
EE
M
M
 2
.5
7,
  
Ph
e-
D
EE
M
M
 2
.4
7,
  
G
ly
-D
EE
M
M
 2
.3
5 
D
EE
M
M
 1
.1
8,
  
Ph
e-
D
EE
M
M
 3
.5
9,
  
G
ly
-D
EE
M
M
 2
.1
4 
 *
**
 
D
B
E
M
M
 
[M
+H
]+
, 
[M
+N
a]
+ 
 –
Ph
O
H
,  
–2
Ph
O
H
 
D
B
EM
M
 2
.6
4 
D
B
EM
M
 3
.5
6 
**
* 
[M
+H
]+
 
–H
2O
, –
C
O
2, 
 
–P
hO
H
,  
–2
Ph
O
H
 
D
B
EM
M
 2
.5
1 
D
B
EM
M
 2
.4
3 
 *
 
D
N
S 
[M
+H
]+
 
–A
A
, 
–C
O
2, 
 
–S
O
2 
Pr
ob
le
m
s w
ith
 
st
ab
le
 si
gn
al
 
Pr
ob
le
m
s w
ith
 
st
ab
le
 si
gn
al
 
**
 
[M
+H
]+
 
–(
A
A
 a
nd
 S
O
2)
, 
–(
D
N
S 
an
d 
H
2O
), 
 
–(
H
2O
 a
nd
 C
O
) 
D
N
S 
3.
28
 
Pr
ob
le
m
s w
ith
 
st
ab
le
 si
gn
al
 
 *
* 
FM
O
C
-C
l 
[M
+H
]+
, 
[M
+N
a]
+ 
m
/z
 2
63
 is
 
m
on
ito
re
d 
Ph
e-
FM
O
C
 3
.5
3,
  
G
ly
-F
M
O
C
 3
.2
3 
Ph
e-
FM
O
C
 2
.9
5,
 
G
ly
-F
M
O
C
 2
.1
8 
 
* 
[M
+H
]+
 
m
/z
 1
79
 is
 
m
on
ito
re
d 
Ph
e-
FM
O
C
 3
.2
8,
 
G
ly
-F
M
O
C
 3
.1
2 
Ph
e-
FM
O
C
 2
.9
4,
  
G
ly
-F
M
O
C
 2
.4
1 
 *
 
T
A
H
S 
[M
]+
 
 m
/z
 1
77
 is
 
m
on
ito
re
d 
N
/A
 
N
/A
 
* 
N
/A
 
N
/A
 
N
/A
 
N
/A
 
N
/A
 
FO
SF
 
[M
]+
 
 m
/z
 2
98
 is
 
m
on
ito
re
d 
N
/A
 
N
/A
 
**
 
 N
/A
 
 N
/A
 
N
/A
 
N
/A
 
N
/A
 
**
*s
tro
ng
 o
r g
oo
d,
 *
* 
m
ed
iu
m
, *
po
or
 
a  b
as
ed
 o
n 
su
m
 o
f d
ilu
tio
ns
 n
ee
de
d 
fo
r A
r, 
G
ly
, b
-A
la
 a
nd
 T
rp
 (a
m
in
o 
ac
id
s e
va
lu
at
ed
 in
 a
ll 
ca
se
s)
 in
 g
re
en
 te
a 
61
62 
5. SUMMARY 
Present work focused on the evaluation of matrix effect (ME) during deri-
vatization LC-API-MS analysis. ME affects method’s accuracy and sensitivity 
and therefore needs to be assessed during method validation. This can be 
challenging for derivatization LC-API-MS analysis of amino acids, as the 
matrix can influence both derivatization reaction and ionization, moreover, pure 
analytes and analyte free matrices are in most cases not available.  
In present work three methods were used for evaluating the influence of 
sample matrix on LC-API-MS analysis of derivatized amino acids: post-column 
infusion, post-derivatization spiking and sample dilution. Six amino acid 
derivatization reagents, from which two have been developed in our work 
group, were used for analyses involving ESI, APCI and alternating polarity ESI 
ion sources in different experiments.  
Post-derivatization spiking, a method developed in our work group, enabled 
to reveal that in case of analysis of selenoamino acids in onion the sample matrix 
did not affect the derivatization reaction yield for TAHS and DEEMM deri-
vatives. For DEEMM derivatives also ionization matrix effects were neglible. 
However, this approach requires blank matrix which is not always available. 
The post-column infusion experiment showed that ME of the analysis 
depended on the derivatization reagent. Signal suppression of DEEMM-deri-
vatives was caused by buffer solution used for derivatization reaction, while 
other derivatives supressed the signal of FMOC-derivatives. While the former 
underlines the concern for possible ME already in the method development step 
(e.g. optimizing the derivatization procedure), the latter stresses the need for 
chromatographic separation in case of ESI-MS detection.  
The sample dilution approach was used for quantifying the ME. DEEMM 
was found to be least affected by the sample matrix followed by DBEMM, FOSF, 
DNS and FMOC-Cl. TAHS was the most problematic, especially in honey 
matrix, indicating that high ionization efficiency is not neccessarily accom-
panied by low ME. It was found that APCI is less affected by ME than ESI and 
therefore, LC-APCI-MS analysis was considered as an option to reduce ME in 
case of derivatization. In the early steps of method development, it appeared 
that FOSF was not a suitable reagent for APCI, which could be due to the 
permanent charge of the derivatives. LC-APCI-MS methods were development 
for DEEMM, DBEMM, DNS and FMOC-Cl derivatives. Although some sample 
dilution was needed in some cases, APCI was significantly less affected by ME 
than ESI. 
Analysis with DEEMM proved to be most suitable for sensitive and ME-free 
analysis based on the LC-MS analyses of both standard solutions and samples. 
This was further tested in alternating polarity ionization mode for herbal 
extracts and honeys for 22 amino acids. Although some of the derivatized 
analytes suffered from ME in positive ion mode, negative ion mode was in 
general ME-free. Compared to conventional positive ion ESI mode, negative 
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ion ESI and positive ion APCI modes were demonstrated to be less prone to 
ME, while still providing LoQs comparable to positive mode ESI. This provides 
a new principle for developing novel derivatization reagents – derivatization 
reagent with a structure which enhances detectability in these modes could pave 
the road to ME-free LC-MS analysis.  
In conclusion, three methods for evaluating ME in case of derivatization  
LC-MS analysis of amino acids were utilized and their usefulness for 
characterization of different derivatization reagents was demonstrated. Based on 
the ME characteristics, a justified selection of derivatization reagent for analysis 
of low concentrations of amino acids in complex matrices can be made. The 
conclusions made and methods used in this work can be used for developing 
and designing novel derivatization reagents for sensitive and ME-free LC-MS 
analysis.   
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6. SUMMARY IN ESTONIAN 
Aminohapete LC-MS analüüsiks kasutatavate 
derivatiseerivate reagentide iseloomustamine 
Käesoleva töö eesmärgiks oli maatriksiefektide hindamine analüüdi derivati-
seerimist kasutava vedelikkromatograafia massispektromeetria (LC-MS) ana-
lüüsimeetodi korral. Maatriksiefektid halvendavad metoodika tõesust, täpsust ja 
tundlikkust ning seetõttu on neid oluline hinnata metoodika valideerimise käigus. 
Derivatiseeritud aminohapete LC-MS analüüsi maatriksiefektide hindamise teeb 
keeruliseks maatriksi mõju nii derivatiseerimisreaktsiooni saagisele kui ka ana-
lüütide ionisatsioonile MS ioonallikas. Samuti on takistuseks puhaste analüütide 
(aminohappe derivaadid) kättesaadavus ja analüüdivaba maatriksi puudumine 
enamikul juhtudel. 
Proovi maatriksi mõju hindamiseks derivatiseeritud aminohapete LC-MS 
analüüsil kasutati kolme meetodit: kolonnijärgne infuseerimine, derivatiseeri-
misjärgne lisamismeetod ja proovi lahjendamine. Uuriti kuut aminohapete deri-
vatiseerivat reagenti, millest kaks on väljatöötatud meie töörühmas Tartu Üli-
koolis. Töös uuriti nende derivaatide omadusi ESI ja APCI ionisatsiooni 
positiivsete ioonide režiimis ning ESI vahelduva polaarsuse režiimis. 
Meie töörühmas väljatöötatud derivatiseerimisjärgne lisamismeetod võimal-
das kindlaks teha, et sibula maatriks ei mõjutanud TAHS-i ja DEEMM-i deri-
vatiseerimisreaktsioone. Lisaks sellele ei mõjutanud maatriksiefektid DEEMM-
derivaatide analüüsi. Siiski, derivatiseerimisjärgne lisamismeetod ei ole raken-
datav kõigil juhtude, kuna vajab analüüdivaba maatriksit. 
Kolonnijärgse infuseerimismeetodi katsed näitasid, et maatriksiefektid mõju-
tavad erinevaid derivatiseerivaid reagente erineval määral. Kui DEEMM-deri-
vaatide signaal oli maha surutud derivatiseerimisel kasutatava puhverlahuse 
tõttu, siis FMOC-derivaatide signaali surusid maha teised, proovi maatriksi 
komponentidest tekkinud FMOC-derivaadid. Esimest maatriksi mõju on 
võimalik vähendada metoodika väljatöötamise käigus sobivate reagentide vali-
kuga ning teine rõhutab kromatograafilise lahutuse vajalikkust ka massispektro-
meetrilisel analüüsil. 
Maatriksiefekti kvantitatiivseks hindamiseks kasutati proovi lahjendamise 
meetodit. Selgus, et analüüs DEEMM derivaatidega oli kõige vähem maatriksi 
poolt mõjutatud, järgnesid DBEMM, FOSF, DNS ja FMOC-Cl. TAHS oli kõige 
problemaatilisem, eriti meeproovide korral. Probleemid TAHS derivaatidega 
näitavad, et kõrge ionisatsiooniefektiivsusega ei kaasne tingimata maatriksi-
efektivaba analüüs. Näidati, et APCI ionisatsioon on maatriksiefektidest vähem 
mõjutatud kui ESI ja rakendati LC-APCI-MS analüüsi maatriksiefektide 
vähendamiseks derivatiseerimisega aminohapete analüüsil. Juba metoodika 
väljatöötamisel selgus, et FOSF-derivaadid ei andnud APCI ionisatsioonil sta-
biilset signaali, mille üheks põhjuseks võib olla püsiv laeng derivaatidel.  
LC-APCI-MS metoodikad töötati välja DEEMM-i, DBEMM-i, DNS-i ja 
FMOC-Cl-i derivaatide analüüsiks. Kuigi proovi lahjendamine oli vajalik ka 
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APCI meetodis, oli APCI analüüs maatriksi poolt vähem mõjutatud kui ESI 
analüüs. 
Analüüs DEEMM-iga oli nii tundlikkuse kui ka maatriksiefektide poolest 
kõige sobivam LC-MS analüüsiks. DEEMM-derivaate testiti ka vahelduva 
polaarsusega ESI režiimis 22 aminohappe analüüsil mee- ja taimeekstraktides. 
Kuigi positiivses režiimis esines mõnel juhul maatriksiefekte, oli negatiivne 
režiim maatriksiefektidest vaba. Võrreldes tavapärase ESI positiivse režiimiga 
olid maatriksiefektid positiivses APCI ja negatiivses ESI režiimis oluliselt 
väiksemad pakkudes võrreldavaid määramispiire. See avab uue suuna derivati-
seerivate reagentide disainis – just nendes režiimides kõrget ionisatsiooni-
efektiivsust omavad derivaadid võiksid olla teerajajad maatriksiefektivabale 
LC-MS analüüsile.  
Kokkuvõttes, maatriksiefektide hindamiseks derivatiseerimisega aminohapete 
LC-MS analüüsil kasutati kolme meetodit ning näidati nende rakendatavust 
erinevate derivatiseerivate reagentide iseloomustamiseks. Maatriksiefektide 
mõju põhjal on võimalik valida sobiv derivatiseeriv reagent madalate sisalduste 
määramiseks keerulistes proovides. Käesoleva töö järeldusi ja meetodeid saab 
rakendada uute derivatiseerivate reagentide väljatöötamisel tundliku ja 
maatriksiefektivaba LC-MS analüüsi jaoks. 
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